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The skin serves as a semi-permeable barrier that protects the body from pathogens and 
water loss. The stratum corneum, the upper 10-15 µm layer of skin, controls the transport of 
substances into the body and is the primary barrier to transdermal drug delivery. Due to its 
structure, only drugs that are lipophilic and low molecular weight (<500 Da) can penetrate intact 
stratum corneum. This study examines the use of microdermabrasion as a method of removing 
the stratum corneum to increase the skin’s permeability to hydrophilic molecules, proteins, and 
vaccines. Microdermabrasion is a FDA-approved cosmetic skin resurfacing procedure that 
removes the stratum corneum by bombarding it with abrasive particles under vacuum.  The 
stratum corneum is not innervated or vascularized and is constantly being rejuvenated. 
Therefore, removing it does not cause pain, bleeding, or permanent damage. In this thesis we 
will determine for the first time if microdermabrasion can be optimize completely remove the 
stratum corneum, without damaging the viable epidermis, to allow delivery of large hydrophilic 
molecules, proteins, and vaccines into the skin. 
 The aims of this thesis are focused on optimizing the microdermabrasion conditions that 
will selectively remove stratum corneum with and with a mask, evaluating the transport of 
different sized molecules through abraded skin in vitro, and determining the efficacy of insulin 
delivered in vivo and the kinetics of stratum corneum recovery after treatment. The first aim was 
to evaluate selective removal of stratum corneum using microdermabrasion with and without a 
mask. Without the mask, large areas of stratum corneum were removed to increase the skin’s 
permeability. A stainless steel mask was fabricated to further control the three dimensional 
removal of stratum corneum and limit the area of removal, which is important for safety. The 
xix 
 
microdermbrasion machine parameters such as crystal flow rate and the effect of pressure and 
crystal flow on the degree of stratum corneum removal were also characterized. We found the 
degree of stratum corneum removal was more dependant on the exposure time the crystal flow 
rate and not as much on the pressure. Abraded through a mask allowed better control of the 
abrasion area and the mask could be designed to be self limiting feature to prevent damaging the 
viable epidermis. 
For the second aim, sulforhodamine, Texas Red bovine serum albumin, insulin, and 
inactivated influenza vaccine were delivered to porcine and human skin in vitro that was abraded 
with and without a mask. The drugs were delivered for 1 to 54 hours. The drug delivery was 
assessed using horizontal and vertical diffusion cells and the drug concentration was quantified 
using fluorescence. In this aim, the affect of removing the viable epidermis was also evaluated. 
Removing the stratum corneum resulted in an increase in the skin permeability over unabraded 
skin. However, removing the viable epidermis allowed up to ten times higher penetration of the 
drugs than in the skin with stratum corneum removal.  
The third aim evaluated in vivo microdermabrasion drug delivery with a mask and 
examined resealing of the skin after abrasion. Insulin was delivered to diabetic rats with stratum 
corneum or viable epidermis removal. For both cases there was a significant decrease in the 
blood glucose levels. The greatest differences in the two removal groups were the time lag and 
the magnitude of the blood glucose decrease. Removing only the stratum corneum resulted in a 4 
hour time lag, while removing the epidermis resulted in a 30 min time lag. The maximum blood 




The resealing of the skin after abrasion was evaluated for 24 hr in hairless guinea pigs 
using electrical resistance, histology, and a hydrophilic dye to test the permeability of the skin. 
The affect of occlusive and non-occlusive coverings on the rate of stratum corneum recovery was 
also evaluated. Based on the electrical resistance data, we found that the non-occlusive skin 
resealed at a significantly higher rate than the occluded skin. Using histology data we found that 
the dye did not penetrate the skin 12 h after abrasion, which indicates that the stratum was 
recovered and functional.  The difference in the results of the resistance and histology may be 
due to the occluded skin being permeable to ions, but not stratum corneum since it have not been 
fully resealed.  
The results from this thesis show that microdermabrasion has the potential to further the 
field of transdermal drug delivery. In the future, the results from this project can be used to 
increase the number of effective topical drugs and vaccines to increase ease of delivery, increase 








Transdermal drug delivery is the transportation of drugs across the skin’s surface and is a 
highly favorable delivery route since it does not involve the use of needles or cause pain and the 
drugs can avoid the first pass effect of the liver [1]. Despite the ease of drug delivery and the 
large availability of skin, only a few compounds can be administered using transdermal patches 
[1, 2]. The main barrier to transdermal drug delivery is the stratum corneum (SC), the outer most 
layer of skin. The SC is composed of dead flattened keratinocytes that are surrounded by a lipid 
extracellular matrix and its structure only allows low molecular weight (MW<500 Da) lipophilic 
compounds to penetrate intact skin [3].  
Due to the difficulty of crossing the skin’s surface, several techniques have been 
developed to overcome the SC barrier. These techniques include microneedles, thermal ablation, 
jet injectors, electroporation, iontophoresis, and abrasion. Microneedles are micron-size needles 
that penetrate the superficial dermis to deliver drugs and vaccines [4, 5]. They are not as painful 
as a hypodermic needle since they do not penetrate deep enough to stimulate the nerves in the 
dermis [6]. Thermal ablation uses heat generated by lasers or resistive heating to remove the SC 
and have been used to deliver vaccines and protein therapeutics [7-9].  The area of damage 
caused by ablation is often limited to the SC and viable epidermis (VE) to avoid pain and skin 
damage. Jet injectors use pressurized air to rapidly deliver therapeutics to the skin [10]. 
Electroporation and iontophoresis both use electrical current for drug delivery [1]. Abrasion uses 
abrasive particles, such as alumina, to remove the SC [11]. Abrasion can be carried out using 
sandpaper or microdermabrasion [12, 13]. The objective of this thesis is to study the use of 
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microdermabrasion as a method of selectively removing the SC to increase the skin’s 
permeability for drug delivery. 
Microdermabrasion (MDA) is a FDA-approved cosmetic technique that removes the skin 
layers using pressurized abrasive particles. Clinically, it is used to improve the skin’s appearance 
by reducing the appearance of fine lines, wrinkles, and scars [14]. In most of the studies in the 
drug delivery literature, microdermabrasion has been used to partially abrade the SC to deliver 
small molecular weight hydrophilic compounds such as vitamin C (MW 176 Da) [7, 8, 13, 15].  
Those studies did not completely remove the SC. If the SC is completely removed, then larger 
molecules, such as vaccines, can be delivered [12]. Though studies have used MDA to remove 
the SC, there are no studies that have examined the mechanics of abrasion or have characterized 
the MDA device. Studies are also needed to determine the range of drugs that can be delivered 
using MDA and the kinetics of skin healing after SC removal and the effect on drug delivery. 
The aims of this research will evaluate the use of MDA as a drug delivery technique, the efficacy 
of delivered drugs, and rate of skin healing after MDA. 
Specific Aim 1 is to optimize the MDA conditions, using excised porcine skin, that will 
result in selective and complete SC removal, without removing the VE. The second part of the 
aim is to characterize the MDA device to quantify the settings and develop a skin abrasion model 
that correlates the settings to SC removal. Specific Aim 2 is to conduct an in vitro drug delivery 
study to measure the flux of various compounds that are delivered using MDA. Specific Aim 3 
is to conduct an in vivo delivery experiment to deliver insulin and influenza to hairless rats and 
guinea pigs, respectively. This will determine if therapeutic levels of the drugs can be delivered 
using MDA. The kinetics of skin resealing was also examined in hairless guinea pigs to 





Transdermal Drug Delivery 
The drug delivery field is ever evolving to design new technologies that efficiently and 
effectively deliver therapeutics. Currently there are several methods, such as inhalation, oral, and 
injections, that are commonly used to deliver drugs. The delivery route is dependent on the drug 
chemistry and its desired effect and target. Inhalation is a painless method of delivery that is used 
to administer small particles and proteins, such as insulin, to the lungs to elicit a local or 
systemic response. It has been long used as a route of delivery for the treatment of asthma and 
other respiratory ailments. Inhalation delivery has several drawbacks because drugs have to be 
designed to avoid disrupting breathing.  Another disadvantage is that the patients who have 
respiratory ailments may not be able to use certain types of inhaled drugs, such as insulin [16]. 
Oral delivery is usually the most desired method of systemic delivery, due to its ease of 
administration. However, proteins cannot be delivered orally because they are degraded in the 
gastrointestinal tract. Drugs that are taken orally have a low bioavailability due to the first pass 
effect, in which the liver can degrade up to 90-95% of the active drug [17]. Injections are 
efficient in delivering proteins and vaccines locally and to the systemic circulation. Drugs 
delivered by injections are able to avoid the first pass effect, thus increasing the bioavailability of 
the drug and reducing the dosage. Injections are convenient, but are painful and pose a risk of 
disease transmission due to needle reuse and needle-stick injuries [6].  
 Another route of drug delivery is the transdermal route, which utilizes the skin’s anatomy 
to deliver drugs both locally and systemically across the skin’s surface using transdermal patches 
or topical ointments. It can be used to overcome some of the difficulties faced by traditional 
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delivery methods such as pain and the first pass effect. Despite the ease of drug delivery using 
transdermal patches, the anatomy of the skin only allows low molecular weight (MW< 500 Da) 
lipophilic molecules, such as estrogen and nicotine, to penetrate intact skin [1]. As a result, at 
present only 19 drugs or drug combinations have been approved by the FDA to be delivered 
using transdermal patches [1].  
Several novel transdermal delivery technologies such as microneedles, tape stripping, 
chemical enhancers, electroporation, thermal ablation, and abrasion have been developed to 
pierce or remove the SC to increase the skin’s permeability to water soluble molecules [1, 2]. 
Microneedles are micron-size needles that can be fabricated out of glass, metals, or polymers that 
pierce the superficial dermis [1, 4-6, 18, 19]. Therapeutics that are administered using 
microneedles can be delivered as a bolus or in a slower sustained release [4, 5]. Microneedles 
also cause less pain than traditional hypodermic needles due to the shallow depth of insertion [6]. 
Tape stripping involves the use of adhesives, such as tape or glue, to remove SC to increase the 
skin’s permeability. It is widely used for permeability studies, but the procedure is time 
consuming and some anatomical locations require a large amount of stripping for SC removal 
[20].  Chemical enhancers create channels in the SC by disrupting the lipid structure [21]. 
Enhancers increase the skin’s permeability, but strong enhancers can cause skin irritation or 
damage. Ablation utilizes energy generated by lasers or resistive heating to remove SC. Ablation 
can remove small or large areas of SC depending on the drug that is being delivered. The 
procedure is quick and relatively painless since it is limited to the SC. However, laser equipment 
can be expensive and trained personnel is required for the procedure to avoid severely damaging 
the skin [20]. Ablative devices that use resistive heating are portable and safer and easier to use 
than lasers [11]. Abrasion uses coarse paper or pressurized particles to remove the SC [8, 11, 13, 
5 
 
22]. Abrasion can be coupled with a patch or can be carried out using commercially available 
instruments such as the case of MDA [23]. Abrasion is quick, painless, and can completely 
remove the SC. The disadvantage of using abrasion is that it may be difficult to get reproducible 
results due to the heterogeneity in SC thickness and professional MDA equipment requires 
trained technicians. The research of this thesis will examine the use of abrasion, more 
specifically MDA, as a method for drug delivery and we seek to increase its reliability and 
simplicity of use. 
The benefits of the new transdermal delivery technologies is that they can bypass the first 
pass effect, which results in higher bioavailability, fewer side effects, and lower drug doses. 
They also can reduce or eliminate pain associated with drug delivery by selectively piercing or 
altering the SC, which is not innervated. These technologies can be designed to administer single 
doses or release a constant dose over a specific period of time. Compared to traditional methods 
of drug delivery, transdermal drug delivery has the potential to increase patient compliance due 
to the ease of administration and the absence of needles. The drawback to the novel methods is 
that the devices have to be able to compete with current technologies, which despite the 
disadvantages have already been proven to effectively deliver drugs. The newer technologies 
must also be able to deliver therapeutic drug doses.  
Skin Anatomy/Barrier Properties 
 The skin is the body’s largest organ and serves as a protective barrier to the external 
environment and protects against water loss. The skin, shown in Figure 1, is divided into three 
layers: epidermis, dermis, and the subcutaneous fat layer. The epidermis is the outermost layer 
and is further divided into the SC and viable epidermis (VE). The SC is the outermost layer of 
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the epidermis and is 15-20 µm thick. It is composed of dead flattened corneocytes that are 
surrounded by a lipid extracellular matrix. The cells are derived from terminally differentiated 
keratinocytes from the VE and are arranged in a brick and mortar structure [17, 24]. The 
corneocytes undergo desquamation, the process of naturally shedding from the SC every two 
weeks [21]. Due to the SC structure, only low molecular weight (<500 Da) lipophilic compounds 
can diffuse across intact SC. 
 
Figure 1. A picture of intact porcine skin. The skin layers are labeled: SC=stratum corneum, VE=viable epidermis, 
and D=dermis. 
The VE is located beneath the SC and the thickness ranges from 50 to 200 µm depending 
on the anatomical location [21, 24]. The VE provides structural support and contains many cell 
types such as melanocytes, which give the skin its pigmentation, and immune cells that protect 
the body during injury [24]. Unlike the SC which contains only 20% water, the VE is 70% water 
and is more permeable to water soluble compounds [21, 24]. The VE is mainly composed of 
proliferating epithelial cells that will eventually undergo the process of cornification to become 
terminally differentiated keratinocytes that will become SC. The kerotinocytes originate from 
proliferating cells in the basal lamina, the epithelial cell layer that separates the VE from the 
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dermis. Since the VE is not vascularized, the basal lamina receives nutrients and oxygen via 
diffusion from the dermal capillaries. As the kerotinocytes migrate away from the basal lamina 
and move toward the skin’s surface, they undergo the process of cornification. During 
cornification, the organelles disappear and the intracellular space becomes filled with keratin 
[24]. The cells flatten out and eventually become the SC. The cells will eventually undergo 
desquamation and shed from the SC and will be replaced with underlying keratinocytes. It takes 
four weeks for cells to migrate from the basal layer to the skin’s surface [24]. 
 The dermis is 2 to 4 mm thick and contains nerves, blood vessels, and the skin 
appendages, such as hair follicles and sweat glands. The dermis is composed of mainly Type I 
collagen and elastin and provides structural support for the skin [25]. The dermis also provides 
the nutrients and oxygen to the epidermal cells. The dermis contains dermal dendritic cells that 
protect the skin from pathogens during injury [11, 26]. Beneath the dermis is the subcutaneous 
layer. It is primary composed of adipocytes and it functions to provide warmth to the body and 
structural support [24].  
Microdermabrasion 
As mentioned in the transdermal drug delivery section, abrasion can be used as a method 
of disrupting SC to increase the skin’s permeability to water soluble drugs and compounds. The 
focus of the research presented in this thesis will be to examine the use of microdermabrasion as 
a transdermal drug delivery method. Microdermabrasion (MDA) is an FDA-approved cosmetic 
procedure that was developed in 1985 to reduce the appearance of large pores, fine lines, 
wrinkles, tattoos, and scars [14, 27].  MDA works by removing SC with abrasive particles, such 
as alumina or sodium chloride, under vacuum. Removing SC induces an inflammatory response 
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that results in increased collagen remodeling and proliferation which produces the positive 
cosmetic results seen after MDA, such as noticeably firmer skin [28]. The MDA machine works 
by placing the handpiece on the skin and occluding the opening of the plastic tip with the skin. A 
schematic of the MDA machine is shown in Figure 2. The crystals flow from the machine into 
the handpiece inlet port to impel and abrade the skin. While the crystals are flowing to the skin, 
used crystals and skin debris are shunted back through the outlet port to the machine and 
collected in a waste container. The closed-loop system prevents cross contamination among 
patients. The procedure is painless, short, and requires no down time for recovery. Typically, 
MDA is performed at spas or in a cosmetic surgeons’ office as an outpatient procedure by 
doctors or technicians. 
 
Figure 2. MDA machine schematic. Crystals flow from the reservoir and impel the skin, then the used crystal and 
skin debris flow back into the machine into the waste container. 
9 
 
Until recently, MDA has been used only for cosmetic purposes. Recently more studies 
have been conducted on using MDA for drug delivery. One such study that demonstrated the use 
of MDA for drug delivery was published in 2004 by Lee, et al. Their study used MDA to deliver 
vitamin C (MW 176 Da), a very low molecular weight hydrophilic molecule, to nude mice skin 
after MDA [8]. Although they were able to deliver 15 times more vitamin C in abraded skin than 
the unabraded control sample, the study did not completely remove the SC. They also delivered 
vitamin C to tape stripped skin, where the SC was completely removed, and they were able to 
deliver 157 times more vitamin C than the unabraded control [8]. Other studies that did not 
completely remove the SC have been successful in delivering other very low molecular weight 
hydrophilic drugs such as 5-aminolevulinic acid (MW 168 Da) and 5-fluorouracil (MW 130 Da), 
which are both used to treat local skin ailments [7, 13]. The studies conducted by Lee the others 
were limited to low molecular weight compounds. These studies did not address delivery of 
larger molecules (MW>500 Da), which we hypothesize requires full removal of SC. 
Skin abrasion has been shown to be successful for delivering vaccines to elicit an 
immune response. In a study conducted by Gill et al., that formed the preliminary data for this 
thesis, it was demonstrated that MDA can be used to selectively and completely remove the SC 
in humans and monkeys for drug delivery. Modified Vaccina Ankara (MVA), a vaccine, was 
delivered to abraded monkey skin that had complete SC removal and a measurable antibody 
response was obtained [12]. Due to its large size, MVA cannot penetrate intact skin, so this study 
demonstrated the importance of completely removing the SC for macromolecule and vaccine 
delivery. Another study developed a portable disposable skin abrasion device that delivered 
vaccines and adjuvants, such as cholera toxin and heat-labile E. coli enterotoxin, for traveler’s 
diarrhea [29, 30]. The device was also used to deliver adjuvants for vaccine dose sparing to 
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reduce the amount of vaccine that was needed to elicit an immune response [23, 29, 30]. The 
abrasion device consisted of abrasive paper that disrupted the SC to increase the skin’s 
permeability to the molecules. Vaccines were delivered to skin that was only abraded with the 
device, while adjuvants were delivered to skin that was treated with an intramuscular injection of 
a vaccine. Using the device, an increase in IgG antibodies were reported in mice, guinea pigs, 
and humans that were administered vaccines or adjuvants [23, 29, 30].  
Studies have also delivered hydrophobic drugs, such as estradiol and clobetasol, using 
MDA [13, 15]. Estadiol and clobetasol can both diffuse across intact skin due to their small size 
and lipophilicity (MW<500 Da). The estradiol study demonstrated a higher penetration depth of 
estradiol in abraded hairless mice skin than the unabraded control [15].  However, the clobetasol 
study showed higher molecule penetration in unabraded porcine skin as opposed to abraded skin 
[13]. The conflict in the results may be due to the difference in the compounds molecular 
weights and the animal models they used. These studies suggest that hydrophobic compounds 
may be less suitable for delivery using MDA, however there are many hydrophobic substances 
that can transverse intact skin and are used in current transdermal therapies.  
Most previous studies only partially removed SC and demonstrated increased flux of low 
molecular weight compounds across skin. Our preliminary studies demonstrated complete and 
selective removal of SC, which was associated with increased skin permeability to particulate 
viral vaccine. In this thesis we sought to establish a more detailed relationship between MDA 
conditions and SC removal and to determine its effects on skin permeability to macromolecules. 
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Skin Mechanical Properties 
 The skin is a nonlinear viscoelastic heterogeneous composite material and each layer has 
its own unique mechanical properties [31, 32].  The SC is a stiff layer that has a breaking 
strength of 6 to 2000 MPa, depending on the level of hydration and the testing method used for 
measurement [33]. The modulus of the SC helps it to withstand daily interactions with the 
outside environment. The VE and dermis are less rigid than the SC. The VE is mostly composed 
of epithelial cells and differentiating keratinocytes. The dermis is composed of collagen and 
elastin, which gives the skin its elastic nature that allows it to return to its original state after 
applied tensile stress [24]. The SC and dermis are more commonly studied in mechanical tests 
than the VE. Studies that measure the skin’s mechanical properties usually use suction, 
indentation, or tensile tests to determine the modulus and breaking strength of the skin layers.  
 The mechanical properties of the skin are important in maintaining the skin’s integrity. 
An imbalance in the mechanical properties, especially the SC, results in barrier pathologies that 
put the body at risk of infections and dehydration. Novel technologies that aim to target the SC 
either by piercing or removal must consider the mechanical properties. The technologies must be 
able to exert forces that are larger than the breaking strength of SC for penetration or removal. 
For MDA, understanding the mechanical properties of the skin will explain why certain abrasion 
conditions are able to remove SC more effectively than others. It will also explain the rapid 
destruction of VE after the SC is removed if the procedure is not properly controlled. 
Vaccine Delivery and Immunity 
Vaccines are commonly inactivated, live, or attenuated pathogens that are administered to 
impart immunity against future infections. Vaccines have successfully led to the eradiation of 
12 
 
polio in developed countries and small pox throughout the world [34, 35]. Currently, most 
vaccines are delivered either by subcutaneous or intramuscular injections, which are relatively 
convenient, inexpensive, and have been proven to elicit an effective immune response. However, 
needles are painful, carry the risk of needle-stick injuries, and have a high disposal cost [11]. 
Newer delivery methods are being researched to target the VE to decrease vaccine dosage, 
increase the vaccine immunogenicity, and reduce or eliminate needle use.  
The VE, located beneath the SC, is populated with many immune cells such as 
Langerhans cells and the dermis contains dermal dendritic cells and macrophages that act as the 
first line of defense to fight pathogens in breached skin [11, 26].  Delivery to the VE targets the 
Langerhans cells, the largest population of epidermal immune cells. Langerhans cells are 
antigen-presenting dendritic cells that function to activate T cells during microbial invasion. 
When the skin is breached, the antigen binds to the Langerhans cell and is internalized and 
processed into a single strand oligonucleotide. The oligonucleotide is then presented to T cells 
through major histocompatibility complex class II interactions on the cell surface. This antigen 
presentation activates T cells to initiate an immune response to the pathogen [26]. The 
abundance, location, and T cell activation action of the Langerhans cells make the epidermis 
possibly a better target for vaccine delivery than traditional methods. 
Some of the newer epidermal and dermal vaccine delivery methods include abrasion, 
intradermal injections, and jet injections [11]. Abrasion systems use micron-sized projections or 
abrasive paper to abrade the SC to allow topical vaccine delivery [23, 36]. The vaccine can either 
be administered in the form of a liquid or patch. One vaccine that has been delivered by abrasion 
is influenza [23, 36]. Some abrasion vaccine formulations also contain adjuvants, compounds 
that enhance the immune response. This increased immune response leads to a decrease in the 
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amount of vaccine needed for immunity [23, 36]. The advantage to using abrasion is that it is fast 
and results in minor skin irritation and pain and uses smaller doses of vaccine [36]. The 
drawback is that the SC must be effectively disrupted to allow the vaccine to cross the skin 
surface.  
Intradermal injections use needles to penetrate into the dermis for vaccine delivery [11]. 
The needles can either be hypodermic needles or micron-size needles [19, 37]. Vaccines that are 
delivered using intradermal injections are smallpox, tuberculosis, BCG, and sometimes rabies. 
The advantage to using skin vaccination is that it can use smaller doses of vaccine and it may 
elicit a more robust immune response than traditional delivery methods. The disadvantage is that 
targeting the skin is difficult and may require special training [11].  
Jet injectors use pressurized liquids or powders to administer vaccines to the skin [10, 11, 
38, 39]. The liquid creates micron-sized channels that allow the entry of the pressurized vaccine 
into the skin. Vaccines such as smallpox, measles, polio, meningitis, and yellow fever have been 
delivered using jet injection systems. Jet injectors are quick and the resulting vaccination has an 
immune response that is equal to or better than traditional injections. The disadvantage to using 
jet injector systems is that they can be painful and there is a risk of disease transmission among 
patients due to blood splatter contamination [11].  
Along with targeting the skin, mucosal points of entry into the body have also been 
targeted for vaccine delivery to take advantage of the large number of immune cells present in 
mucosal tissue. One mucosal delivery method is inhalation, which is used to deliver vaccines to 
the nasal passages and lungs [40]. Products such as FluMist
TM
, which was approved by the FDA 
in 2003, have been developed to delivery influenza using inhalation [11]. The nasal passages are 
populated with immune cells and are a common entry way for airborne pathogens. The 
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advantage to using inhalation delivery is that it can result in a stronger immune reaction as 
compared to common injections.  The drawbacks are that it may be difficult to deliver a 
consistent dose, the vaccine may affect the cranial nerves, and virus can be possibly transmitted 
to others by spraying the drug [11]. 
Skin Resealing after Injury 
 The skin’s main function is to protect the body from the external environment and when 
it is breached due to injury, its ability to restore the barrier is important to protect the body from 
pathogens and water loss. The rate of skin recovery is determined by the depth and severity of 
the wound. Superficial wounds, which reach into the superficial dermis (200 µm deep), exhibit 
rapid healing and do not result in the formation of a scar [41, 42]. Injuries that occur deep in the 
dermis and subcutaneous fat layer often result the formation of a scar and require a longer time 
for barrier recovery [41]. To heal properly, deep wounds often require closing either by sutures 
or bandages to reduce the gap in the area of tissue damage [42].  
After injury, the skin heals in three phases: inflammation, reepithelialization, and tissue 
remodeling [43]. The inflammation phase occurs within a few minutes after injury and involve 
the activation of neutrophils and the release of cytokines and growth factors [43]. The cytokines 
and growth factors stimulate fibroblast proliferation and also attract monocytes that circulate in 
the blood to the site of injury to fight pathogens that may have entered the skin [43]. These cells 
release chemicals in the inflammation phase initiate the healing process. 
Reepithialization or tissue formation occurs within hours or can take up to one week after 
injury [41, 43]. During reepithialization the stem cells in the basement membrane proliferate to 
repair the damaged area and cells from appendages migrate to the injury site [43]. Organisms 
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that have a higher density of appendages, such as rodents, exhibit a more rapid healing response 
to injury [44]. If the wound is deep (extending deep into the dermis) granular tissue will form 
during the reepithialization phase. The granular tissue is composed of macrophages, fibroblast, 
and connective tissue. The fibroblasts produce collagen that will repair and replace the damaged 
tissue. Neovascularization also occurs to form new blood vessels [43]. 
The final step of healing is tissue remodeling and it occurs two to four weeks after injury. 
Wound contraction occurs during this phase to close the wound. Excess connective tissue that 
was formed during the reepithialization phase is degraded by matrix metollaproteinases (MMP) 
to remodel the tissue back to its natural form and function [43]. Depending on the depth and 
severity of the wound, a scar may remain after the final phase of healing [41]. 
The rate of wound healing can be affected by the type of dressing that is applied to the 
wound. Wound covers are grouped into three categories: occlusive, semi-occlusive, and non-
occlusive. Occlusive covers prevent oxygen from diffusing into the wound and also prevent the 
wound from losing moisture. In a study conducted on humans and pigs, occlusive dressings were 
shown to accelerate the rate of reepithialization and prevent the formation of eschars (scabs) 
[45].  However, occlusion can also delay the formation functional SC after injury [46]. Semi-
occlusive coverings allow oxygen to diffuse into the site and wound retains its moisture. In a 
study conducted by Visscher et al. it was found that semi-occlusive membranes promoted better 
healing than occlusive and non-occlusive membranes for tape stripped skin [47]. Non-occluded 
wounds remain open to the environment. Oxygen can penetrate the injury site and the wound 






MATERIAL AND METHODS 
 
Controlled Pore Formation in Stratum Corneum Using Microdermabrasion 
Microdermabrasion Procedure        
Microdermabrasion experiments were conducted on excised adult feeder porcine (2-9 
month old, average weight 32 kg) dorsal skin (Pel-freeze Biologicals, Rogers, AR) using a Gold 
Series MegaPeel microdermabrasion machine (DermaMed USA, Lenni, PA) with the gold 
handpiece assembly.  Pig skin was obtained with approval from the Georgia Tech Institutional 
Animal Care and Use Committee (IACUC). The skin was stored at -70 °C prior to use. Before 
the experiments were conducted, subcutaneous fat was removed from the skin using a scalpel 
(Fisher Scientific, Fair Lawn, NJ) and the hair was carefully removed using surgical prep razors 
(Medex Supply, Monsey, NY) without damaging the skin.  
A picture of a microdermabrasion machine tip and the alumina crystals are shown in 
Figure 3A and B, respectively. The experiments were carried out using two different abrasion 
modes: static and dynamic. For the static mode, the machine handpiece remained stationary on 
the skin for 6 s. For the dynamic mode, it was moved along the skin for 10 passes at a rate of 1 
pass/s. The dynamic mode experiments were carried out by first isolating the area of abrasion 
with a rectangular foam adhesive (Avery Dennison, Painesville, OH) having inner dimensions 
measuring 41 mm long and 15 mm wide and sliding the probe back and forth within this area. 
For both abrasion modes, the effect of crystal flow rate and suction pressure were examined. The 
crystal flow rate was varied from the minimum value (corresponding to a setting of 9 turns of the 
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crystal flow rate knob on the microdermabrasion machine) to the maximum value (corresponding 
to a setting of 0 turns of the crystal flow rate knob). As discussed in the Appendix, we 




 particles/s or <0.01 to 0.80 
g/s of particles. The suction pressure was also varied from -30 kPa to -60 kPa. All experiments 
were carried out in triplicate. 
 
Figure 3. Microdermabrasion device and mask. (A) Microdermabrasion machine handpiece and (B) the alumina 
abrasion crystals (~100 µm in diameter). (C) Stainless steel mask with 408 holes (125 µm diameter). (D) Schematic 
diagram of the skin after abrasion with the mask, where the stratum corneum is selectively removed and the 
underlying layers are intact. SC = stratum corneum, VE = viable epidermis, and D = dermis. 
We also studied the effect of time on depth of skin abrasion as a function of the crystal 
flow rate and pressure for the static and dynamic abrasion modes using porcine skin. For the 
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static mode, the crystal flow rate was fixed at 4 turns and the time points studied were 3, 20, and 
45 s at suction pressures of -30, -40, and -50 kPa. For the dynamic mode, the flow rate was set to 
4.5 turns and the suction pressures examined were -25 and -45 kPa for 1, 10, and 50 passes. All 
experiments were carried out in triplicate. 
At the conclusion of each experiment, an 8 mm skin biopsy was taken with a biopsy 
punch (Miltex Inc, York, PA) and embedded in Optimal Cutting Temperature (OCT) compound 
(Sakura Finetek, Torrance, CA) and frozen in dry ice for histological analysis. The skin was 
sectioned using a Leica 3050S cryostat (Leica Microsystems, Wetzlar, Germany) at a thickness 
of 10 µm, stained with routine hematoxylin and eosin (H&E), and imaged using a Nikon 600E 
microscope (Nikon, Tokyo, Japan) and Qcapture software (Q Imaging, Pleasanton, CA). 
Abrasion Depth Quantification 
The depth of abrasion was quantified by assigning values to indicate the degree of 
stratum corneum removal. For the experiments in which the time was held constant, 0 indicated 
stratum corneum not removed, 0.5 represented partial stratum corneum removal, and 1 for 
complete stratum corneum removal. For the experiments in which the time was varied, 0 was 
assigned for stratum corneum not removed, 0.5 for partial stratum corneum removal, 1 for 
complete stratum corneum removal, and 1.5 for viable epidermis removal. For each condition 10 
histological sections from 3 replicate experiments were examined and scored. Average scores are 




Microdermabrasion Using a Skin Mask  
To control the area of abrasion, two masks with an array of holes (125 µm or 250 µm diameter) 
were designed using AutoCAD software (Autodesk, San Rafael, CA) and fabricated out of 
stainless steel (75 µm thickness, Trinity Brand Industries, Countryside, IL). The pattern was cut 
into the metal using an infrared laser (Resonetics Maestro, Nashua, NH) and the masks were  
manually cleaned with detergent (Contrex, Decon Labs, King of Prussia, PA) to de-grease the 
surface and remove slag and oxides deposited during laser cutting, which was followed by 
thorough rinsing in running deionized (DI) water. To deburr and clean edges, the masks were 
electropolished in SS Electropolish solution (E972, ESMA, South Holland, IL). The process was 
carried out in an electropolisher (model no. E399-100, ESMA, South Holland, IL) using 6 V for 
15 min. After electropolishing, the masks were cleaned by dipping alternately three times in de-
ionized water and 25% nitric acid (Fisher Scientific, Fair Lawn, NJ) for 30 s each. This was 
followed by another washing step in hot running water and a final wash in running de-ionized 
water. Due to the electropolishing process, the thickness of the masks was reduced to 50 μm. 
Masks were dried using compressed nitrogen. 
For the microdermabrasion experiments, the mask was adhered to the center of a 
rectangular foam adhesive (Avery Dennison, Painesville, OH) and attached to the skin. A picture 
of the mask and a schematic of the skin after abrasion are shown in Figure 3C and D, 
respectively. In experiments using the mask, excised porcine cadaver skin was abraded at a 
pressure of -50 kPa at the maximum crystal flow rate (0 turns) for 30, 45, 60, 90, and 120 s to 
determine the optimal removal setting. The site of abrasion was revealed by staining with green 
dye (McCormick & Co, Hunt Valley, MD). After the experiment, the area of abrasion was 
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excised and frozen for histological examination using the same protocol as mentioned in the 
previous section.  
Statistical Analysis 
Statistical analysis was carried out using Minitab software (Minitab Inc., State College, 

















Transdermal Delivery of Macromolecules Using Microdermabrasion 
Abrasion Protocol 
All the microdermabrasion experiments without the use of the mask were conducted on 
excised full thickness adult feeder porcine dorsal skin (2-9 month old, average weight 31.8 kg, 
Pel-freeze Biologicals, Rogers, AR) using a Gold Series MegaPeel MDA machine (DermaMed 
USA, Lenni, PA) with the gold handpiece assembly. The subcutaneous fat was removed with a 
scalpel (Fisher Scientific, Fair Lawn, NJ), although a thin layers of the subcutaneous tissue 
remained adherent, and the hair was shaved with surgical prep razors (Medex Supply, Monsey, 
NY) prior to the experiment. The abrasion area was bounded by a window cut out of a piece of 
rectangular adhesive foam (L=41 mm and W=15 mm) applied to the skin and the 
microdermabrasion handpiece was moved along the skin within the window in the adhesive 
foam at a constant speed of 1 pass/s at suction pressures of -25, -45, and -50 kPa for 10 or 50 
passes at a crystal flow rate of 0.35 g/s (4.5 turns of the crystal flow rate knob). 
Sulforhodamine Delivery 
Sulforhodamine B (SR, Invitrogen, Carlsbad, CA), a fluorescent molecule, was used as 
the low molecular weight hydrophilic drug model. The molecular weight is 558 g/mol. Each 
delivery experiment was conducted by first generating a standard curve by measuring the 




M with a spectrofluorimeter 
(Photon Technology International, Birmingham, NJ). The area under the emission curve for each 
concentration was calculated by Felix Fluorescence Analysis Software (Photon Technology 
International, Birmingham, NJ).  The solution concentrations and the area under the emission 
curves were plotted for the standard curve.   
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The delivery experiments was carried out by abrading the skin at two vacuum pressures, -
25 and -45 kPa, for 10 and 50 passes each. The crystal flow rate was set to a crystal flow rate of 
0.36 g/s (4.5 turns of the crystal flow rate knob). After abrasion, the treated skin and an untreated 
control were placed in horizontal diffusion cells (PermeGear, Bethlehem, Pa) with a water jacket 
set to 37 °C. Three milliliters of 10
-3 
M SR and phosphate buffered saline (PBS, Sigma-Aldrich, 
St. Louis, MO) were added to the donor and receiver chambers, respectively. The skin was 
exposed for 1, 6, or 24 h. The concentration of SR was quantified by emptying the receiving 
chamber solution every hour and measuring the fluorescence with the spectrofluorimeter. Fresh 
PBS was added to the receiving chamber at each sampling point. The 24 h experiments were 
split into two 12 h experiments that measured SR diffusion from hours 1 to 12 and 13 to 24. The 
1 to 12 h experiment was conducted by sampling the receiving chamber solution for the first 12 
h. For the 13 to 24 h experiment, the receiving chambers were not sampled for the first 12 h. At 
hour 12, the receiving chambers were emptied, washed three times with PBS, and filled with 
fresh PBS. The receiving chambers were then sampled from 13 to 24 h. Three replicates for each 
time point were carried out. At the conclusion of the experiments, the skin was embedded in 
Optimal Cutting Temperature compound (Sakura Finetek, Torrance, CA) and frozen in dry ice 
for histological analysis. Shown in Appendix C is the experimental setup for the in vitro drug 
delivery experiments.  
Bovine Serum Albumin Delivery 
Texas Red-labeled bovine serum albumin (BSA, Invitrogen, Carlsbad, CA), a fluorescent 
labeled protein, was used as a model compound for protein delivery. BSA has a molecular 
weight of 66 kDa. The porcine skin was abraded at a pressure of -50 kPa for 50 passes at half of 
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the maximum crystal flow rate to remove the stratum corneum. The penetration was studied in 
the same manner as SR, except the skin was placed in vertical Franz cell diffusion chambers 
(PermeGear, Bethlehem, Pa). The Franz cells permitted the use of a smaller donor solution 
volume. The Franz cells were placed in a heating blocking (PermeGear, Bethlehem, Pa) that was 
set to 37 °C. One hundred microliters of 10
-5
 M BSA and 5 mL of PBS were added to the donor 
and receiver chambers, respectively. The skin was exposed to BSA for 1, 6, and 24 hours. The 
flux was not measured since it was determined in separate experiment that BSA did not penetrate 
the entire skin thickness in 24 hours.  At the completion of the experiment the skin was frozen, 
sectioned, and imaged to assess the molecule penetration depth.  
Inactivated Influenza Vaccine Delivery 
The model vaccine used for delivery was inactivated influenza virus (MW 3.0x10
6 
Da). 
Influenza virus was conjugated to R18 (octadecyl rhodamine B chloride) for fluorescent 
imaging. To conjugate R18 to the virus, 10 µL R18 was mixed with 200 μL (3 mg/ml) of 
inactivated virus. The solution was incubated for 1 hr at room temperature, then ultracentrifuged 
at 28000 rpm for 1 hr to remove unbound R18. After centrifugation, 1 mL 20% sucrose, 9 mL 
PBS (without Ca, Mg), and 1 mL inactivated virus formulation (200 µL R-18 stained inactivated 
virus, 0.7 mL PBS, and 0.1 mL fetal bovine serum) were mixed. The supernatant was removed 
and 200 µL of PBS was added to resuspend the solution overnight at 4 
o
C. The abrasion settings 
and the diffusion experiments for influenza was conducted using the same abrasion and delivery 
protocol as the BSA experiment. Histology was used to assess the penetration depth.  Due to its 




Mask Delivery Study 
Excised split thickness human cadaver skin (National Disease Research Interchange, 
Philadelphia, PA) that was dermatomed to a thickness of 200 to 600 µm was used to deliver 
sulforhodamine B (SR) and insulin using microdermabrasion. The skin was abraded through a 
polymer mask to reduce the area of abrasion. The masks were fabricated out of 70 µm thick 
polyethylene terephthalate (McMaster Carr, Aurora, OH) and the holes (125 µm diameter) were 
laser cut with a Hermes LS500XL CO2 laser (Gravograph, Duluth, GA). One pass of the laser 
was used and the power and speed were set to 15% and 10%, respectively.  
The mask was adhered to the skin using tape (Fisher Scientific, Fair Lawn, NJ) and the 
skin was abraded using the conditions -30 kPa at a crystal flow rate of 0.23 g/s (5 turns of the 
crystal flow rate knob) for 20 s and -50 kPa at a crystal flow rate of 0.95 g/s (0 turns of the 
crystal flow rate knob) for 60 s to remove the stratum corneum and viable epidermis, 
respectively. Three replicates of each condition were used for the experiment. Three positive and 
negative controls were also used for both experiments. The negative controls were not abraded 
and were exposed to the drug. The positive controls were abraded, but were only exposed to 
PBS. The microdermabrasion tip was moved to multiple sites on the mask to maximize the area 
of abrasion. After abrasion, the pores were revealed with green dye (McCormick & Co, Hunt 
Valley, MD) and photographed using an Olympus SZX12 stereoscope (Olympus, Tokyo, Japan), 
Leica DC 300 camera (Leica Microsystems, Wetzlar, Germany), and Adobe Photoshop software 
(Adobe Systems, San Jose, CA). The skin was placed in Franz cell diffusion chambers and the 
chambers were housed in a heating block set to 37 °C. At the conclusion of both delivery 
experiments, the area of abrasion was re-revealed using green dye and the skin was snap frozen 
in dry ice for histological analysis. The skin was sectioned at a 10 µm thickness with a Microm 
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cryostat (Thermo Fisher, Walldorf, Germany). The sections were photographed to measure the 
molecule penetration depth with a Nikon E600 microscope (Nikon, Tokyo, Japan) and Qcapture 
camera and software (Q Imaging, Pleasanton, CA).  The slides were stained with routine H&E in 
a Leica autostainer (Leica Microsystems, Wetzlar, Germany). 
For the SR delivery experiments, 200 µL of 10-3 M SR and 5 mL of PBS were added to 
the donor and receiver chambers, respectively. The donor chamber was covered with parafilm 
(Pechiney Plastic Packaging, Chicago, IL) to reduce evaporation. The receiver chamber was at 
each time point. The SR concentration in the receiving chamber was measured, using 
fluorescence, in the same manner as the SR experiments in the previous section.  
To measure insulin diffusion, 100 µL of a U500 Humalog-R (Eli Lilly, Indianapolis, IN) 
mixture was added to the donor chamber. The Humalog mixture consisted of 80 µL of U500 and 
20 µL of FITC-labeled bovine insulin (Sigma-Aldrich, St. Louis). The bovine insulin was used to 
visualize insulin diffusion during the histological analysis. The receiving chamber contained 5 
mL of PBS mixed with 0.01 M sodium azide (Sigma-Aldrich, St. Louis, MO), a preservative. 
The donor chamber was covered with parafilm and the donor solution was replaced at each 
sampling time due to the instability of U500 insulin. The receiving chamber was sampled every 6 
hours for 54 hours in the same manner as the SR experiments. The concentration of the FITC-
labeled bovine insulin was measured using fluorescence using the same protocol as the SR 
experiments. The total insulin concentration in the receiving chamber solution was additionally 
quantified using a rat insulin enzyme-linked immunoassay (ELISA) kit (Alpco Diagnostics, 
Salem, NH), which had cross-reactivity with the Humalog insulin used in this study. The assay 
was carried out according to the manufacturer’s protocol.  
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Transdermal Insulin Delivery Using Microdermabrasion 
Microdermabrasion Protocol 
The The skin was microdermabraded using a Gold Series MegaPeel machine (DermaMed 
USA, Lenni, PA), with the gold handpiece assembly, through a polyethylene terephthalate 
polymer mask to control and reduce the area of abrasion. The mask, shown in Figure 4, was an 
array of 408 holes (125 μm in diameter) with a center to center spacing of 500 µm. The masks 
were fabricated out of 70 µm thick polyethylene terephthalate (McMaster Carr, Aurora, OH) and 
the holes were laser cut with a Hermes LS500XL CO2 laser (Gravograph, Duluth, GA). Prior to 
abrasion, the skin was gently cleaned with alcohol swabs (Becton and Dickinson, Franklin 
Lakes, NJ) and allowed to air dry. The mask was adhered to the skin with tape (Fisher Scientific, 
Fair Lawn, NJ) and the area of abrasion was maximized by moving the microdermabrasion tip to 
different sites on the mask. The skin was abraded at a suction pressure of -30 kPa for 30 s at a 
crystal flow rate of 0.19 g/s (6 turns of the crystal flow rate knob) to remove the stratum 
corneum. The viable epidermis was removed using a suction pressure of -50 kPa for 60 s at a 
crystal flow of 0.95 g/s (0 turns of the crystal flow rate knob). After abrasion, green dye 
(McCormick & Co, Hunt Valley, MD) was applied to the skin for 20 s and wiped cleaned with 




Figure 4. The polymer mask used for the insulin delivery study. The 408 holes (125 μm diameter) were drilled into 
the mask using a CO2 laser. The mask was adhered to the skin with tape and the microdermabrasion tip was placed 
on it, at multiple sites, to maximize the area of abrasion. 
Diabetes Induction Protocol 
Rapid acting U100 Humalog-R insulin (Eli Lilly, Indianapolis, IN) was delivered to 39 
six weeks old diabetic hairless rats (CD Strain, Charles River Laboratories, Wilmington, MA). 
Prior to the experiment, the rats were allowed unrestricted access to food and water. The animal 
protocol was approved by the Georgia Institute of Technology Institutional Animal Care and Use 
Committee. To induce diabetes, the rats were weighed to determine the streptozocin (Sigma-
Aldrich, St. Louis, MO) dose. They were anesthetized with isoflurane and the blood glucose was 
measured using a NovaMax meter (Nova Biomedical, Bedford, MA) with blood obtained from a 
tail vein laceration. Two hundred microliters of blood, also from the tail vein, was collected in 
blood serum tubes (Capiject, Somerset, NJ) for insulin quantification. The rats were injected, in 
the tail vein, with 300 µL of 80 or 100 mg/kg of streptozocin. Initially 100 mg/kg was used, but 
the dose was lowered to 80 mg/kg to reduce mortality and severe hyperglycemia. The 
streptozocin was dissolved in 4 °C citrate buffer (pH 4.5, Sigma-Aldrich, St. Louis, MO) and 
sterilized by filtering with a 0.2 µm pore syringe filter (Fisher Scientific, Fair Lawn, NJ) 
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immediately before the injection. Twenty four hours after streptozocin administration the rats 
were re-weighed to verify that there was no more than a 20% weight loss. The rat was 
anesthetized with isoflurane and the blood glucose was measured and diabetes was deemed to be 
induced if the blood glucose exceeded 300 mg/dL. Only rats with <20% weight loss and blood 
glucose levels higher than 300 mg/dL were used for the study. 
Insulin delivery protocol 
The rats were divided into four groups: negative control, positive control, stratum 
corneum abrasion, and viable epidermis abrasion. The negative control group was not abraded 
and did not receive insulin. The positive control group received a 500 µL subcutaneous injection 
of 0.1 U of insulin. To prepare the insulin for the injection, 50 µL of U100 Humalog-R was 
diluted in 25 mL of sterile phosphate buffered saline (Mediatech, Manassas,VA).  
After the animals were determined to be diabetic, the rats remained anesthetized and 
untreated for one hour to make sure the blood glucose levels were stable (i.e., animals with 
>20% variation were not used).  After the stabilization hour, the animals were treated according 
to their group. A transdermal patch (Altea Therapeutics, Atlanta, GA) filled with 200 µL of a 
solution containing 80% Humalog-R (100 U/mL) and 20% FITC-labeled bovine insulin (2.5 
mg/mL, Sigma-Aldrich, St. Louis, MO) was applied to the site of abrasion in the stratum 
corneum and viable epidermis removal groups. The bovine insulin allowed visualization of the 
insulin penetration depth for the histological analysis. The blood glucose was measured every 30 
min for the first 2 h and every 2 h for hours 2 to 8. Two hundred microliters of blood was 
collected at each time point for insulin quantification using enzyme-linked immunoassay 
(ELISA). The insulin-filled patches were removed at the 4 h time point and the skin was wiped 
29 
 
clean with Kimwipes (Kimberly-Clark, Dallas, TX). The animals remained under anesthesia 
until they were euthanized with carbon dioxide at the conclusion of the experiment. Animals 
were euthanized during the experiment if their blood glucose exceeded 475 mg/dL or fell below 
45 mg/dL. 
Serum Insulin Determination 
 The rat blood was allowed to clot at room temperature for two hours after collection. The 
blood was centrifuged (Eppendorf AG, Hamburg, Germany) at 1200 g for 10 min. After 
centrifugation, the serum was removed and stored at -70 °C. The concentration of Humalog and 
the endogenous rat insulin in the serum was quantified using a rat insulin ELISA kit (Alpco 
Diagnostics, Salem, NH) that detected both Humalog and rat insulin. The rat insulin kit was used 
because ELISA insulin kits that detected Humalog also cross reacted with endogenous rat 
insulin. Human insulin kits were not used because they cannot detect Humalog since the amino 
acid structure of native insulin and synthetic insulin differ. The assay was carried out according 
to the manufacturer’s protocol.  
Data Analysis 
The area under the curve for the blood glucose and serum insulin data was determined 
with NCSS software (NCSS LLC, Kaysville, UT). The statistical analysis was performed using 
Minitab software (Minitab Inc., State College, PA). A one-way ANOVA was conducted on the 





Skin Repair Kinetics after Stratum Corneum Removal Using 
Microdermabrasion in Hairless Guinea Pigs 
 
Skin Abrasion Protocol 
Sixteen hairless guinea pigs (Charles River Laboratories, Wilmington, MA) were divided 
equally into four groups that corresponded to the skin healing time points. Two additional guinea 
pigs were used for a sham experiment. The animal protocols were approved by the Georgia 
Institute of Technology Institutional Animal Care and Use Committee. Prior to the experiment, 
the animals were given free access to food and water. The dorsal skin was prepared for abrasion 
by thoroughly cleaning with alcohol swabs (Becton and Dickinson, Franklin Lakes, NJ) and 
allowing it to air dry. The abrasion area was marked using a rectangular foam adhesive (Avery 
Dennison, Painesville, OH) that had a length of 41 mm and a width of 15 mm. Each guinea pig 
was abraded in two sites on the back on opposite sides of the spinal column that were not in 
contact with each other. The guinea pigs were abraded using a DermaMed Gold Series 
microdermabrasion machine (DermaMed USA, Lenni, PA) with the gold tip assembly. The skin 
was abraded at a suction pressure of -40 kPa, at half of maximum crystal flow, by moving the 
microdermabrasion tip back and forth along the abrasion area for 10 passes (1 pass/s). After 
abrasion, one site was occluded with a non-gel electrode (Thought Technology, Montreal, 
Canada) and Blenderm Tape (3M, St. Paul, MN). The area was further secured with Tegaderm 
(3M, St. Paul, MN) and a Coban elastic bandage (3M, St. Paul, MN) to prevent the animal from 
disturbing the site. The other abraded site remained uncovered. An additional site on the back 
was used for the negative control and was not abraded or occluded. For the sham experiments, 
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microdermabrasion was performed without crystals or pressure for 10 passes (1 pass/sec) on the 
two guinea pigs after euthanasia. 
Electrical Resistance Measurements 
Electrical resistance was used to monitor the stratum corneum barrier recovery after 
microdermabrasion treatment at 0, 4, 12, and 24 hours after abrasion. The four animal groups 
corresponded to the skin healing monitoring time points. The guinea pigs were lightly sedated 
with isoflurane and the baseline skin impedance for every group, except for sham, was measured 
using a resistance reader (EIM-105 Prep-Check, 30 Hz, modified with a 200 kΩ resistor in 
parallel; General Devices, Ridgefield, NJ, USA) one and two hours prior to the experiment and 
three minutes before abrasion [48]. A gelled reference electrode (Lead-Lok Biomedical 
Innovations, Sandpoint, ID) was placed on the upper back near the base of the skull. A non-gel 
electrode (Thought Technology, Plattsburg, NY) was used to measure the resistance of the 
negative control and two abrasion sites. The non-gel electrodes were adhered to a thin foam 
adhesive (Avery Dennison, Painesville, OH) that isolated the measurement site and prevented the 
electrode’s adhesive from damaging the skin. The resistance was measured 4, 12, and 24 hours 
after abrasion. Each group included all the measurements prior to the designed endpoint. For 
example, the 24 hour group included resistance readings at 4, 12, and 24 hours after abrasion. 
The actual value of the skin resistance was determined by subtracting the meter’s inline 200 kΩ 
resistor from the measured value and multiplying the values by the electrode contact area. All 
statistical tests were performed by Minitab software (Minitab Inc, State College, PA). A P value 
of less than 0.05 was considered significant. A two way ANOVA and a Student’s t-test was used 
for all the statistical evaluations. 
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Dye Penetration Test 
All the animals were sacrificed using pentobarbital at the designated endpoint. The 
animals’ time group indicated the time of euthanasia; for example the zero hour group animals 
were euthanized immediately after abrasion. After euthanasia, 100 µL of 10
-2
 M sulforhodamine 
B (Invitrogen, Carlsbad, CA) was applied to the abrasion sites, using a cotton swab, for 15 min 
to determine if the stratum corneum was reformed and mature.  Sulforhodamine is a hydrophilic 
molecule that will not penetrate intact skin. After the incubation, the sulforhodamine B was 
removed by gently cleaning the skin with deionized water and Kimwipes (Kimberly-Clark, 
Neenah, WI) and the skin was excised for histological analysis. 
All tissue samples were embedded in Optimal Cutting Temperature compound (Sakura 
Finetek, Torrance, CA), and snap frozen in dry ice for histological analysis. The skin was 
sectioned using a Leica 3050S cryostat (Leica Microsystems, Wetzlar, Germany) at a thickness 
of 10 µm. The sulforhodamine B fluorescence was photographed before the sides were stained 
with routine hematoxylin and eosin (H&E). All the slides were imaged using a Nikon 600E 











CONTROLLED PORE FORMATION IN STRATUM CORNEUM USING 
MICRODERMABRASION 
 
Microdermabrasion has been shown to increase skin permeability for transdermal drug 
delivery by damaging or removing skin’s outer layer, stratum corneum. However, relationships 
between microdermabrasion parameters and effects on the stratum corneum barrier have not 
been developed. In this study, we determined the effect of microdermabrasion crystal flow rate, 
time, and suction pressure applied in both static and dynamic modes on the extent of stratum 
corneum removal from excised porcine skin. In addition to controlling the depth of tissue 
removal by microdermabrasion parameters, we also controlled the area of tissue removal by 
applying a metal mask patterned with 125- or 250-µm holes to selectively expose small spots of 
tissue to microdermabrasion. We found that the extent of stratum corneum removal depended 
strongly on the crystal flow rate and exposure time and only weakly on pressure or 
static/dynamic mode operation. Masking the skin was effective to localize stratum corneum 
removal to exposed sites. Overall, this study demonstrates that optimized microdermabrasion in 
combination with a mask can be used to selectively remove stratum corneum with three-
dimensional control, which is important to translating this technique into a novel method of 
transdermal drug delivery. 
Introduction  
Transdermal drug delivery involves the administration of drugs, usually from transdermal 
patches or topical formulations, across the skin’s surface and typically into the systemic 
circulation [1, 49]. This is a convenient and desirable route of delivery because skin offers a 
large area for delivery, therapeutics can be administered in a consistent dose that avoids the first 
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pass effect of the liver, and needle-free delivery avoids pain and the dangers associated with 
hypodermic injection. Despite the ease of drug delivery using transdermal patches and ointments, 
the anatomy of skin only allows small amounts of low molecular weight, lipophilic molecules, 
such as estrogen and nicotine, to penetrate intact skin at therapeutic levels. This is because the 
main barrier to transdermal transport is the stratum corneum, which is the outer 10-15 µm layer 
of skin. The stratum corneum is composed of nonviable corneocytes that are surrounded by a 
lipid extracellular matrix. The viable epidermal and dermal layers beneath the stratum corneum 
typically offer much less resistance to drug transport.  
To overcome the stratum corneum barrier and increase skin’s permeability to hydrophilic 
and macromolecular compounds, the stratum corneum is often pierced for injection or removed 
by stripping, ablation, or abrasion [50, 51]. Devices that pierce the stratum corneum involve the 
use of hypodermic needles, microneedles, or jet injectors [52, 53]. These methods lend 
themselves to bolus delivery and are typically either invasive, painful or both. Stratum corneum 
removal can be done by tape stripping, but the procedure is time consuming and requires expert 
technique [15]  Ablation utilizes energy generated by lasers or heating elements to remove the 
stratum corneum [51]. Abrasion uses sandpaper or pressurized particles, such as 
microdermabrasion, to remove the stratum corneum [7, 8, 12, 13, 15, 54]. The advantage to using 
abrasion is that it is quick and painless, and that microdermabrasion is already approved by the 
FDA for other applications. However, current microdermabrasion equipment requires detailed 
characterization to determine conditions that selectively remove stratum corneum for transdermal 
drug delivery. Because it is the rate-limiting barrier, removal of stratum corneum by 
microdermabrasion can dramatically increase skin permeability, even to large molecules 
including proteins and vaccines [12].  
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Microdermabrasion is an FDA-approved cosmetic procedure that was developed in the 
1980’s to reduce the appearance of large pores, fine lines, wrinkles, tattoos, and superficial scars 
[14].  Microdermabrasion damages the stratum corneum by bombarding it with abrasive 
particles, such as alumina or sodium chloride, under vacuum [55]. Damaging stratum corneum 
induces an inflammatory response that results in increased collagen remodeling and proliferation, 
which produces the positive cosmetic results seen after microdermabrasion treatment, such as 
noticeably firmer skin [56].  
The microdermabrasion machine works by placing a handpiece on the skin, which 
occludes the opening of the plastic tip to create a vacuum. Upon tip occlusion, the crystals flow 
from the machine into the inlet port and abrade the skin. At the same time, the skin debris and 
used crystals are shunted back through the outlet port to the machine and collected in a waste 
container. This closed-loop system prevents cross-contamination between patients and exposure 
of medical personnel. Typically, patients undergo several sessions of microdermabrasion, 
depending on the severity of the skin condition, to improve the skin’s appearance [28, 56]. The 
procedure is noninvasive, painless, and short, and requires no down time for recovery. Typically, 
microdermabrasion is performed at spas or by cosmetic surgeons or dermatologists. 
Several studies have shown that microdermabrasion can be used to increase transdermal 
delivery of low molecular weight compounds such as vitamin C (176 Da), 5-aminolaevulinic 
acid (130 Da), 5-Fluorouracil (467 Da), lidocaine (234 Da) and estradiol (272 Da) [7, 8, 13, 15, 
39]. We also showed in a previous study that microdermabrasion can be used to completely 
remove the stratum corneum in humans and monkeys and demonstrated increased skin 
permeability to fluorescein (332 Da) and a model viral vaccine (Modified Vaccina Ankara) [12].  
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Microdermabrasion can also be used in conjunction with a mask to control the area of abrasion 
and deliver drugs to the skin[39]. 
Building off these previous findings, this study sought to develop a microdermabrasion 
method that offers three-dimensional control over stratum corneum removal, which should 
provide improved control over transdermal drug delivery. Control over depth of abrasion, and 
the ability to completely remove stratum corneum without damaging deeper tissue, was pursued 
through a detailed analysis of the effects of microdermabrasion crystal flow rate, time, suction 
pressure, and handpiece movement. To control the area of abrasion, we designed a mask to cover 
the skin and allow microdermabrasion to occur only through small holes in the mask, thereby 
localizing tissue removal to specific locations. In this way, we could control the size of holes 
made in the skin by microdermabrasion in all three dimensions.  
 
Results 
Control Over Depth of Microdermabrasion by Optimization of Operating Parameters 
To control depth of microdermabrasion, this study sought to understand how the primary 
microdermabrasion operating parameters of crystal flow rate, suction pressure, time, and 
handpiece movement affected stratum corneum removal.  
Static Mode 
For the static mode, the microdermabrasion handpiece was held stationary against the 
skin for 6 s at the specified conditions. The skin was abraded at suction pressures of -30, -40, -
50, and -60 kPa at 1, 4, and 9 turns of the crystal flow rate knob. A setting of 1 turn of the crystal 
flow rate knob corresponded to a flow rate of ~2x10
5
 particles/s or ~0.7 g/s at an average 
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velocity of ~1.5 m/s. A setting of 4 turns corresponded to a flow rate of ~1x10
5
 particles/s or 
~0.3 g/s at an average velocity of ~2 m/s. The flow rate was too low for accurate quantification 
at a setting of 1 turn, but the average velocity was found to be ~3 m/s. See the Appendix for 
more information about these measurements and calculations.  
For reference, Figure 5 shows an intact piece of skin without microdermabrasion 
treatment. The full thickness of red-stained stratum corneum is present, the blue-stained nuclei of 
the viable epidermis are seen below, and the pink-stained dermis is deeper still.  
 
Figure 5. Histological section of intact porcine cadaver skin stained with H&E. The stratum corneum appears on top 
with a red stain. Viable epidermis is immediately below with characteristic blue staining of epidermal cell nuclei. 
The pink-stained dermis is below that.  
Figure 6 and Figure 7 show the results of the static mode experiments. Figure 6 presents 
histological images of representative skin sections after microdermabrasion and Figure 7 
quantifies these data by scoring the extent of stratum corneum removal and averaging among 
replicates. Overall, as the crystal flow rate increased, the degree of stratum corneum removed 
increased for all pressures (Figure 7, two-way ANOVA, P < 0.05). Pressure did not significantly 
affect stratum corneum removal (Figure 7, two-way ANOVA, P > 0.05). As shown in the left 
column of Figure 6, microdermabrasion at the most aggressive crystal flow rate (1 turn) 
completely removed the stratum corneum from skin abraded at pressures of -50 and -60 kPa and 
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partially removed at pressures of -30 and -40 kPa. Partial stratum corneum removal is indicated 
by bits of stratum corneum still adherent to the skin surface. The viable epidermis remained 
intact under these conditions, except at -60 kPa, which had small focal areas of deeper tissue 
removal.  
 
Figure 6. Skin abraded using static mode microdermabrasion at -30, -40, -50, and -60 kPa suction pressure for 1, 4, 
and 9 turns of the crystal flow rate knob. Crystal flow rate scales inversely with the number of knob turns, such that 
1 turn corresponds to the largest crystal flow rate (see Appendix for more information). Representative H&E-stained 




Figure 7. Degree of stratum corneum removal during static mode microdermabrasion at -30, -40, -50, and -60 kPa 
suction pressure at 1, 4, and 9 turns of the crystal flow rate knob. Complete stratum corneum removal = 1, partial 
stratum corneum removal = 0.5, and stratum corneum not removed = 0. Data represent the average of three replicate 
measurements. No error bars are shown because all three measurements at each condition gave identical results.  
 The intermediate crystal flow rate (4 turns) resulted in partial stratum corneum removal 
at all suction pressures (Figure 6, center column). For all suction pressures at the lowest crystal 
flow rate (9 turns), the stratum corneum remained intact (Figure 6, right column). At 9 turns, the 
greatest contribution to possible tissue removal appeared to be suction pressure, because there is 
very little crystal flow.  
We also sought to evaluate the effect of time on the amount of stratum corneum removal. 
For the static mode, the skin was abraded at suction pressures of -30, -40, and -50 kPa for 3, 20, 
and 45 s at 4 turns of the crystal flow rate knob. The histological results for the static mode are 
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shown in Figure 8. Quantification of the amount of stratum corneum removed is presented in 
Figure 9. For all pressures, at 3s, the stratum corneum remained intact (Figure 8 left column). 
However, at 20 and 45 s stratum corneum and viable epidermis were removed at all pressures 
tested ((Figure 8 center and right columns). Overall, time had a significant effect on tissue 
removal (Figure 9, two-way ANOVA, P < 0.05), but the effects of pressure were not significant 
(Figure 9, two-way ANOVA, P > 0.05). These results demonstrate the importance of exposure 
time on the depth of abrasion, in addition to the important role of crystal flow rate demonstrated 
above. 
 
Figure 8. Skin abraded using the static mode at -30, -40, and -50 kPa suction pressure at 4 turns of the crystal flow 
knob applied for 3, 20, and 45 s. Representative H&E-stained sections of porcine cadaver skin are shown. Scale bar 




Figure 9. Degree of stratum corneum removal during static mode microdermabrasion at -30, 40, and -50 kPa suction 
pressure at 4 turns of the crystal flow knob applied for 3, 20, and 45 s. Viable epidermis removal=1.5, complete 
stratum corneum removal = 1, partial stratum corneum removal = 0.5, and stratum corneum not removed = 0. Data 
represent the average of three replicate measurements. Error bars are not shown to simplify the presentation. 
Dynamic Mode 
For the dynamic mode experiments, the skin was abraded at the same crystal flow rates 
and suction pressures as the static mode, but the microdermabrasion handpiece was moved 
across the skin for 10 passes at a rate of 1 pass/s. Figure 10 presents histological images of 
representative skin sections after microdermabrasion and Figure 11 quantifies these data. Similar 
to the static mode, increasing the crystal flow rate significantly increased the amount of stratum 
corneum removal (Figure 11, two-way ANOVA, P < 0.05), whereas suction pressure did not 
have a significant effect (Figure 11, two-way ANOVA, P > 0.05). At the most aggressive crystal 
flow rate (1 turn), the stratum corneum was completely removed for all pressures and the viable 
42 
 
epidermis remained intact (Figure 10, left column).  At 4 turns of the crystal flow rate knob, the 
stratum corneum was partially removed for all pressures (Figure 10, center column). At 9 turns, 
the stratum corneum remained intact on the skin (Figure 10, right column).  
 
Figure 10. Skin abraded using dynamic mode microdermabrasion at -30, -40, -50, and -60 kPa suction pressure for 
1, 4, and 9 turns of the crystal flow rate knob. Crystal flow rate scales inversely with the number of knob turns, such 
that 1 turn corresponds to the largest crystal flow rate (see Appendix B for more information). Representative H&E-




Figure 11. Degree of stratum corneum removal during dynamic mode microdermabrasion at -30, 40, -50, and -60 
kPa suction pressure at 1, 4, and 9 turns of the crystal flow rate knob. Complete stratum corneum removal = 1, 
partial stratum corneum removal = 0.5, and stratum corneum not removed = 0. Data represent the average of three 
replicate measurements. No error bars are shown because all three measurements at each condition gave identical 
results. 
  For the dynamic mode time experiments, the number of passes was set at 1, 10 or 50 
passes, which was performed using suction pressures of -25 and -45 kPa at 4.5 turns. The 
histological images of skin and quantitative analysis of the degree of stratum corneum removal is 
shown in Figure 12 and Figure 13, respectively. For both pressures at 1 pass, the stratum 
corneum remained intact (Figure 12 right column). At the 10 passes, the skin treated at -25 kPa 
had partial stratum corneum removal and skin abraded at -45 kPa had complete stratum corneum 
removal (Figure 12 middle column). At 50 passes, both samples had complete stratum corneum 
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removal (Figure 12 left column). For all times and pressures the viable epidermis remained 
intact. Through quantitative analysis of these experiments, however, neither time (Figure 13, 
two-way ANOVA, P = 0.07) nor pressure (Figure 13, two-way ANOVA, P > 0.05) was found to 
have a statistically significant effect. This lack of statistical significance is possibly due to the 
small sample size, because only two pressures were examined.  
 
Figure 12. Skin abraded using the dynamic mode microdermabrasion at -25 and -45 kPa suction pressure at 4.5 
turns of the crystal flow rate knob applied for 1, 10, and 50 passes. Representative H&E-stained sections of porcine 




Figure 13. Degree of stratum corneum removal during dynamic mode microdermabrasion at -25 and -45 kPa 
suction pressure at 4.5 turns of the crystal flow rate knob applied for 1, 10, and 50 turns.  Complete stratum corneum 
removal = 1, partial stratum corneum removal = 0.5, and stratum corneum not removed = 0. Data represent the 
average of three replicate measurements. Error bars are not shown to simplify the presentation. 
Control over Area of Microdermabrasion by Using a Mask  
We have shown above that optimization of microdermabrasion parameters can control 
the depth of stratum corneum removal. Next, we wanted to control the area of removal and 
thereby achieve three-dimensional control over pore formation. To accomplish this, we designed 
a mask to partially cover the skin’s surface and, in that way, only expose selected spots on the 
skin to microdermabrasion (Figure 3C).  
Mask Design 
  In the experiments to optimize microdermabrasion conditions presented above, a single, 
large area of skin (i.e., many cm
2
) was abraded. Abrading such a large area may be cosmetically 
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unacceptable, take too long to heal, and present increased risk of infection. For that reason, we 
now introduce the use of a mask to make an array of microscopically small pores. While we 
wanted the holes in the mask to be as small as possible, they also needed to be large enough to 
permit the microdermabrasion crystals to flow through and contact the skin. Larger holes also 
reduced the chances of occlusion due to particle clogging. Because the particles have a diameter 
of about 100 µm, we selected a hole size of 125 µm. Center-to-center spacing between the holes 
was set at 500 µm. 
Mask thickness was also a concern, because a thicker mask would increase the distance 
between the skin and the crystal flow from the machine, making particle entry into the hole to 
contact the skin more difficult. However, a thinner mask might be excessively damaged during 
the abrasion process (i.e., the crystals not only abrade the skin, but also abrade the mask). Given 
these constraints, we selected a mask thickness of 50 µm. Made out of stainless steel, this mask 
provided sufficient durability, but was also sufficiently flexible to conform to the skin surface.  
Lastly, we found that the presence of hairs was an important factor because hairs 
impeded good contact between the mask and the skin. Moreover, the hairs themselves served as 
masks that blocked microdermabrasion crystals from contacting the skin. This may not be as 
great a concern for use in humans. However, the very thick hairs present on the porcine skin used 
in this study needed to be shaved for good results.  
Microdermabrasion Using a Mask 
The effect of the mask during microdermabrasion was assessed using the static abrasion 
mode at a suction pressure of -50 kPa for 30, 45, 60, 90, and 120 s at the maximum crystal flow 
rate (0 turns). For all times, complete removal of stratum corneum was observed and the viable 
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epidermis remained intact, as shown in Figure 14. We used these relatively aggressive 
microdermabrasion conditions because of the expectation that the presence of the mask would (i) 
reduce the effectiveness of microdermabrasion and (ii) provide a possible self-limiting effect due 
to the inability of microdermabrasion crystals to penetrate deeply through the narrow holes in the 
mask.  
 
Figure 14. Skin abraded using a mask containing 125 µm-diameter  holes at -50 kPa suction pressure and the 
maximum crystal flow rate (0 turns) for 45 s (A), 60 s (B) and 90 s (C).  (D) Skin abraded using a mask containing 
250 µm-diameter holes at -50 kPa suction pressure  at the maximum crystal flow rate for 30 s. The arrows point to 
sites of SC removal. (E) Skin abraded at the same condition as (A) without the mask; both the SC and VE were 
removed.  (F) Skin abraded at the same condition as (B) imaged en face at lower magnification to show the holes 
stained with green dye. SC = stratum corneum, VE = viable epidermis, and D = dermis. 
Histological examination presented in Figure 14A– Figure 14C shows representative 
pores formed in the skin. Their depth spans the full thickness of the stratum corneum, but 
without damaging viable epidermis. The average width of the pores was 87 ± 22 µm, based on 
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measurement of 10 pores from 3 different skin samples. This pore size is somewhat smaller than 
the mask hole size probably because microdermabrasion crystals, which abrade the skin by 
impacting it primarily at an angle, have difficulty abrading skin along the edges of the mask hole.  
Figure 14F shows a lower-magnification, en face view of the skin surface after 
microdermabrasion at the same conditions used in Figure 14B. Staining with a green dye shows 
pore formation in the skin following the pattern of the mask (Figure 3C). Closer examination of 
the pores shows that the green-stained spots have an average diameter of 118 ± 39 µm, based on 
measurement of 10 pores from 3 different skin samples. Some of the pore diameters were larger 
than the mask hole diameter and the pore size shown by histology, possibly due to lateral 
diffusion of dye within the skin. 
In Figure 14D, microdermabrasion was carried out using a mask with 250 µm diameter 
holes. This larger mask hole size led to removal of stratum corneum as well as much of the 
viable epidermis.  This shows that mask hole size not only affects the area of tissue removal but 
also affects the depth of tissue removal. In Figure 14E, skin was microdermabraded at the same 
condition as the skin in Figure 14A, but without any mask. In this case, not only was the area of 
skin abrasion large, but the full epidermis was removed. This further shows that the mask not 
only limits the area of abrasion, but also influences the depth. The observation that 
microdermabrasion with the 125-µm mask was independent of exposure time over the range of 
30–120 s studied here further suggests a self-limiting feature enabled by the mask. We 
hypothesize that microdermabrasion crystals are only able to penetrate to a limited depth into the 
mask holes and this limits how much tissue they can remove. Moreover, we observed the holes 
to become clogged with microdermabrasion particles over time. This may close off holes and 
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thereby stop further skin abrasion after a period of time. More work is needed to fully understand 
this self-limiting feature.  
Discussion 
This study showed for the first time that controlled microdermabrasion using optimized 
operating parameters in combination with a mask enabled three-dimensional control of tissue 
removal that selectively and completely removed small spots of stratum corneum without 
removing the viable epidermis. Selective removal of stratum corneum is important because 
damage to the viable epidermis causes trauma to living tissue that could be painful, take longer 
to heal, and generate cosmetically undesirable appearance. Complete removal of stratum 
corneum is important because this is needed to eliminate the primary barrier to drug delivery.  
We studied the effect of crystal flow rate, suction pressure, exposure time, and handpiece 
movement on stratum corneum removal and found that crystal flow rate and exposure time had 
the greatest impact on stratum corneum removal. Over the range of conditions studied, suction 
pressure had no significant effect. Both static and dynamic handpiece movements were effective. 
We believe that the crystal flow rate was important because the crystals shear and tear the 
stratum corneum and, therefore, the number of times crystals impact the skin should correlate 
with the degree of tissue removal [14].  The exposure time was also an important parameter for 
similar reasons; increased exposure time increased the number of crystal-skin impacts. The 
suction pressure, in contrast, had no significant effect on the crystal flow rate or velocity (see 
Appendix) and, correspondingly, no significant effect on tissue removal. We believe that the 
suction pressure serves to help remove skin debris and crystals from the skin surface and into the 
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refuse canister of the microdermabrasion machine. In this way, suction is important to proper 
function of the microdermabrasion method, but it does not control the tissue removal process.  
The importance of crystals in microdermabrasion has been shown in a previous study in 
which inclusion of crystals increased the expression of proteins needed for dermal remodeling, 
which is the primary purpose of conventional cosmetic microdermabrasion, as compared to 
suction pressure alone [57].  However, suction pressure alone (i.e., without crystals) has been 
shown to remove stratum corneum at pressures of -20 to -40 kPa when the skin was exposed for 
24 s [33]. Although similar suction pressures were applied in this study for up to similar periods 
of time (≤ 45 s static mode and ≤ 50 s dynamic mode), no stratum corneum removal was 
observed without significant crystal flow. While the different exposure times may play a role, the 
fact that our study used pig skin in vitro and the study that removed stratum corneum with 
suction alone used human skin in vivo may also be relevant. Consistent with this expectation, a 
previous study with human skin in vivo found that static mode microdermabrasion at conditions 
that removed stratum corneum also caused microblisters (i.e., localized separation of epidermis 
from the underlying dermis) [12] but this was not observed in the present study using pig skin in 
vitro. This suggests that human skin in vivo may be more susceptible to suction-induced damage 
than pig skin in vitro.  
Both handpiece abrasion modes resulted in selective stratum corneum removal, however 
the dynamic mode appears to offer advantages (in addition to the lack of microblisters found 
previously [12]. For example, stratum corneum removal in the static experiments was not as 
uniform as in the dynamic experiments and the area of tissue removal is limited to that of the 
microdermabrasion tip (0.4 cm
2





this study) and the results were more consistent. Additionally, the dynamic mode is typically 
used in the clinical setting for cosmetic microdermabrasion. 
Use of a mask in combination with microdermabrasion limited both the area and depth of 
tissue removal. As discussed above, generating an array of small pores using a mask may be 
preferable from a safety, cosmetic and patient preference perspective compared to removing 
stratum corneum from large, continuous areas of skin. By selecting mask hole diameters not 
much larger than the size of the crystal particles, the mask further served to limit the depth of 
tissue remove, such that 125 µm holes provided a self-limiting feature that achieved selective 
removal of stratum corneum independent of exposure time and using aggressive 
microdermabrasion operating parameters. In this way, the use of a mask was critically important, 
and arguably more important than the microdermabrasion operating parameters, to enable three-
dimensional control over pore formation on the micron scale localized to the stratum corneum.  
The pores generated in this study were on the order of 10 µm deep and 100 µm wide. The 
width of these pores is similar to those created by thermal ablation and piercing with 
microneedles [50, 51, 53], both of which have been well tolerated in numerous human studies 
and both of which enable delivery of a broad range of compounds, including large hydrophilic 
molecules and vaccines. This suggests that the holes made by microdermabrasion should 
likewise be well tolerated and effective for drug delivery. However, the pores made in the 
present study are much less deep that those made by thermal ablation or using microneedles, 
which may make them still better tolerated by patients. 
Comparing more broadly to other methods of transdermal drug delivery, there are several 
additional expected advantages to using microdermabrasion to increase skin permeability. First, 
microdermabrasion is a well-established clinical technique used routinely for cosmetic 
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applications that is safe, minimally invasive, requires no down time, and does not leave scars 
[13]. Competing methods that disrupt stratum corneum structure on the molecular scale, such as 
chemical enhancers, ultrasound, and iontophoresis, are generally limited to delivering low 
molecular weight molecules and small macromolecules, because the stratum corneum is left 
largely intact [1, 49]. Methods that pierce the stratum corneum, such as microneedles, jet 
injectors, and hypodermic needles, can cause pain, require regulated disposal, and may require 
professional help for administration. Other methods that completely remove the stratum 
corneum, such as tape stripping and laser ablation, are generally regarded as impractical for 
widespread use due to cost and reproducibility [7, 15]. In contrast to these other methods, 
microdermabrasion has the advantage of being quick, painless, reproducible and able to generate 




















TRANSDERMAL DELIVERY OF MACROMOLECULES USING 
MICRODERMABRASION 
 
Microdermabrasion is a non-invasive skin resurfacing technique that removes the stratum 
corneum with pressurized abrasive particles. This study examined the use of microdermabrasion 
as a skin permeability method to deliver hydrophilic molecules, proteins, and vaccines. Excised 
full thickness porcine skin was abraded with two conditions that resulted in partial and complete 
removal of stratum corneum.  The skin was exposed to sulforhodamine B, Texas Red bovine 
albumin, and inactivated influenza A vaccine for 1, 6, and 24 hours. The flux of the 
sulforhodamine B was measured and the value for the skin with complete stratum corneum 
removal at 24 hours was 147 times higher than the negative control. Split thickness human skin 
was also abraded through a polymer mask to remove the stratum corneum and viable epidermis 
for delivery of sulforhodamine B and U500 Humalog insulin. The penetration of sulforhodamine 
B and insulin in the skin with the viable epidermis removed was eight times higher than the skin 
with stratum corneum removal. The abrasion depth and the drug molecular weight were the most 
important factors that determined the diffusion rate and penetration depth of the molecule. This 
study demonstrates that microdermabrasion can be used to increase the skin’s permeability to 
water soluble molecule larger than 500 Da. 
Introduction 
Transdermal drug delivery is a highly favored route of drug administration due to the 
skin’s large surface area and ease of administration [1]. The advantages are that it avoids drug 
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degradation due to the first pass effect of the liver, does not involve the use of needles, and does 
not cause pain. Despite the advantages, the skin serves as a barrier that protects the body from 
the external environment and prevents water loss. This barrier function also prevents most 
hydrophilic and large molecular weight drugs (MW>500 Da) from penetrating intact skin. The 
main barrier to transdermal drug delivery is the stratum corneum, the top layer of skin. The 
stratum corneum is composed of dead flattened keratinocytes that are surrounded by a lipid 
extracellular matrix [24]. Some compounds that are lipophilic and have a molecular weight less 
than 500 Da can penetrate intact stratum corneum at useful rates. As a result, only 19 drugs have 
been approved by FDA for delivery in transdermal patches [1]. 
Several transdermal techniques have been developed to pierce or remove the stratum 
corneum to increase the penetration of hydrophilic drugs and proteins to the skin. Such 
techniques include microneedles, chemical enhancers, tape stripping, thermal ablation, and 
abrasion. Microneedles are micron-size needles that pierce through the stratum corneum to 
deliver drugs and vaccines [1, 19, 53, 58-60]. Due to their shallow penetration depth, they cause 
less pain than traditional hypodermic needles [6, 60]. Chemical enhancers alter the lipid structure 
of stratum corneum to increase drug delivery [1, 61]. Tape stripping, thermal ablation, and 
abrasion remove the stratum corneum with adhesives, heat, or abrasive particles, respectively [9, 
13, 50, 53].  This study focuses on the use of abrasion, specifically microdermabrasion, as a 
method of increasing the permeability of water soluble molecules across skin. 
Microdermabrasion is a non-invasive FDA-approved cosmetic technique that reduces the 
appearance of superficial scars and wrinkles [15, 27, 57]. The procedure removes the stratum 
corneum by bombarding it with abrasive particles under vacuum [14, 56]. Although it was 
originally designed for cosmetic use, several published studies that have used microdermabrasion 
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to deliver low molecular weight molecules such as vitamin C (MW 176 Da), 5-aminolevulinic 
acid (MW 168 Da), and 5-fluorouracil (MW 130 Da) to the skin [7, 8, 13]. In those studies the 
abrasion resulted in partial stratum corneum removal.  In another study conducted by Gill et al. 
microdermabrasion was used to completely remove the stratum corneum and Modified Vaccina 
Ankara, a vaccine, was delivered to rhesus macaques monkeys [12]. The vaccine generated a 
measurable antibody response in the monkeys. This study delivered large hydrophilic molecules 
(MW>500 Da) and proteins to skin after controlled microdermabrasion that completely and 
selectively removed the stratum corneum or viable epidermis to examine the barrier properties of 
both layers. This study uses microdermabrasion, with and without a mask, to remove the stratum 
corneum to increase the skin’s permeability to hydrophilic drugs.  
 Results  
Skin Abrasion 
 Shown in Figure 15 is intact skin (picture A), skin abraded without a mask with the 
stratum corneum removed (picture B), and skin abraded with a mask with stratum corneum 
(picture C) and viable epidermis removal (picture D). The intact skin (picture A) has all the 
layers present. The stratum corneum, the top layer, is stained pink and the viable epidermis, 
located directly beneath the stratum corneum, has blue staining indicating the nuclei of the cells. 
The dermis, the third layer, is stained pink and has areas of nuclei staining. Shown in picture B is 
skin that was abraded without a mask. The stratum corneum was removed and the viable 
epidermis remained intact. The skin shown in pictures C and D was abraded through a mask and 
the stratum corneum and viable epidermis were removed, respectively. The arrows point to the 




Figure 15. Shown in the picture is intact skin (A) and skin treated with microdermabrasion, without a mask, with 
the stratum corneum removal (B). Skin abraded through a mask with the stratum corneum removed (C) and viable 
epidermis removed (D). The arrows point to the site of skin removal. 
Sulforhodamine B Delivery 
 The fluorescent images from the full thickness skin SR diffusion experiments that were 
abraded using the condition -45 kPa for 50 passes are shown in Figure 16. The pictures were 
taken at the same exposure time and gain to compare the depth and intensity of the SR at each 
time point. The SR penetration through non-abraded skin was low, as expected. In contrast, the 
SR penetration through abraded skin was significantly larger and increased throughout the 
experiment. The skin that was exposed for 1 h had a detectable amount of SR into the superficial 




Figure 16. SR delivery into skin treated with microdermabrasion (P=-45 kPa for 50 passes). The top row is abraded 
skin and the bottom row is control, unabraded skin, for each time point. 
 The cumulative SR penetration data for the 24 hour experiments are shown in Figure 17. 
The SR penetration in the negative control skin was low, as expected. That result was confirmed 
by the histology shown in Figure 2. In contrast, the sulforhodamine B penetration through 
abraded skin was significantly larger and increased throughout the experiment.  The milder 
settings, 10 passes, resulted in partial SC removal and had lower sulforhodamine B penetration 
than the 50 passes. All the samples had a 12 hr time lag for delivery and steady state was reached 
after the 17
th
 hour. At 24 hr, the skin abraded at -45 kPa for 50 passes had five times more SR 
delivery than -25 kPa for 50 passes. At 24 hours the penetration of the most aggressive setting (-
45 kPa for 50 passes) was 140 times more than negative control. These results are consistent 
with our expectation that microdermabrasion under conditions that remove stratum corneum can 




Figure 17. The cumulative penetration of sulforhodamine B in abraded skin over 24 hours. The control skin (■) had 
the lowest penetration. The skin abraded at -25 kPa  (▲) and -50 kPa (♦) with 10 passes both had a lower 
penetration of sulforhodamine than the same pressures at 50 passes. The sulforhodamine B penetration in the -25 
kPa with 50 passes (x) and -50 kP with 50 passes (●) had similar penetration values up to 12 hr, but the -50 kPa 
penetration greatly increased and exceed the -25 kPa sample from hours 13 to 24. Each line represents three 
replicates. 
Bovine Serum Albumin Delivery 
The fluorescent pictures for the abraded and the control skin that were exposed to Texas 
Red bovine serum albumin for 1, 6, and 24 hours are shown in Figure 18. All the pictures were 
taken at the same exposure time and gain. The pictures on the top and bottom row are the 
abraded skin and negative controls, respectively. Texas Red bovine serum albumin did not 
diffuse the negative control skin. In the abraded skin, the molecule was mainly localized in the 
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viable epidermis as indicated by the layer’s fluorescence intensity. In the skin exposed for one 
hour, the molecule penetrated the viable epidermis and superficial dermis. Texas Red bovine 
serum albumin diffused into the viable epidermis and dermis in the 6 and 24 hour exposed skin; 
however, it did not diffuse into the entire thickness of the dermis. There was no difference in the 
Texas Red bovine serum albumin intensity in the 6 and 24 hours experiments as compared to the 
sulforhodamine B experiments.  The flux was not measured because preliminary diffusion 
experiments showed that Texas Red bovine serum albumin did not diffuse across the dermis. 
 
Figure 18. BSA delivery into abraded skin exposed for 1, 6, and 24 hours. The skin that was treated with 
microdermabrasion is shown on the top row and the control skin on the bottom row. 
 Inactivated Influenza Delivery 
 The histology pictures for the inactivated influenza A vaccine are shown in (Figure 19). 
The vaccine penetrated the 24 hr sample, but not the negative control, 1, or 6 hr sample. The 
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virus particles were larger than sulforhodamine B and Texas Red bovine serum albumin and 
diffused slowly into the skin. The flux and penetration of the influenza virus was not quantified 
since it did not diffuse across the dermis. 
 
Figure 19. Delivery of R18-labeled inactivated influenza A virus to abraded skin for 1, 6, and 24 hr. The top row is 
the abraded skin, while the bottom row is the negative control for the time points. 
Mask Delivery 
The histological results from the split thickness sulforhodamine B experiment are shown 
in Figure 20. Shown on the top row is the skin after abrasion. The area of abrasion was revealed 
using green dye. Picture A and B is the skin that has stratum corneum and viable epidermis 
removal, respectively. Lateral diffusion of the dye can be seen in the viable epidermis 
photograph, indicating a deeper abrasion than the skin with stratum corneum removal. The 
sulforhodamine B penetration is shown the skin with stratum corneum removal (picture C) and 
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viable epidermis removal (picture D). The pictures were taken at the same exposure time and the 
viable epidermis removal picture had a higher concentration of sulforhodamine B as indicated by 
the dye intensity. The bottom row is the H&E stained pictures of the skin after sectioning. The 
arrows point to the area of abrasion. 
 
Figure 20. Human split thickness skin that was abraded through a mask to remove the stratum corneum (A) and 
viable epidermis (B). The area of abrasion was revealed with green dye. The skin with the stratum corneum (C) and 
viable epidermis (D) removed was exposed to sulforhodamine B for 12 hr. Pictures E and F are the H&E stained 




 The cumulative penetration results for sulforhodamine B delivery to split thickness skin 
with stratum corneum and viable epidermis removal after masked abrasion are shown in Figure 
21. Sulforhodamine B did not penetrate the intact negative control skin. Removing the viable 
epidermis significantly increased the flux and penetration of the molecule in the skin in 
comparison to removing only stratum corneum. The skin with viable epidermis removal had a 
seven times higher penetration than the stratum corneum removal group. Both samples reached 
steady state within four hours.  
 
Figure 21. Sulforhodamine delivery in split thickness abraded skin, through a polymer mask, for 12 hours. 
Sulforhodamine did not penetrate the negative control skin (■). The penetration in the skin with viable epidermis 
(VE) removal (♦) was seven times higher than the stratum corneum (SC) removal (▲) group at 24 hours.  
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 An insulin solution consisting of 80 % U500 Humalog and 20 % FITC-labeled bovine 
insulin was delivered to skin with SC and VE removal after abrasion using a mask. The histology 
pictures for the insulin delivery experiments are shown in Figure 22. The top row is the 
fluorescent images of the FITC-labeled bovine insulin penetration in the skin and shown on the 
bottom row is the H&E pictures of the skin. The arrows are pointing to the site of stratum 
corneum removal (C) and viable epidermis removal (D). Since the skin was exposed to the donor 
chamber for 54 hrs the affect of over-hydration is present in the H&E pictures. 
 
Figure 22. Skin abraded and exposed to U500 and FITC-insulin bovine insulin for 54 hours. Pictures A and C is the 
skin with stratum corneum removal, while pictures B and D is the skin with viable epidermis removal. The arrows 
point to the area of abrasion. 
The penetration of the FITC-labeled bovine insulin was measured using florescence and 
is shown in Figure 23. The insulin penetration in the VE removal skin was 17 times higher than 
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the skin with SC removal at the end of the experiment. The insulin did not penetrate the negative 
control. The skin with the stratum corneum removed had a lower FITC-insulin penetration than 
the skin with viable epidermis removal. The insulin penetration in the viable epidermis removal 
skin was 17 times higher than the skin with stratum corneum removal at the conclusion of the 
experiment. 
 
Figure 23. The cumulative penetration of FITC-labeled bovine insulin that was delivered to split thickness human 
skin that was abraded through a mask. The FITC did not penetrate the negative control skin (♦). The penetration of 
the FITC-labeled bovine insulin in the viable epidermis group (▲) was higher than the stratum corneum group (■). 
At the conclusion of experiment, the penetration of the skin that had viable epidermis removal was 17 times higher 
than the skin with the stratum corneum removed. Each line represents three replicates. 
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The amount of insulin that was delivered was determined using ELISA and results are 
shown in Figure 24. The concentration of insulin delivered in the skin that with viable epidermis 
removal was almost ten times higher than the stratum corneum removal group. Both removal 
groups were significantly higher than the negative control. The ELISA information confirms the 
fluorescence measurements in showing that the removing the viable epidermis increases the 
amount of insulin that can be delivered. 
 
Figure 24. Shown in the graph are the ELISA results for the insulin delivery experiment. The stratum corneum 
removal (■) concentration ranged from 10 to 58 ng/mL and the viable epidermis group (▲) concentration ranged 




By using microdermabrasion to remove the stratum corneum, we were able to 
demonstrate that hydrophilic molecules and proteins with a molecular weight larger than 500 Da 
can be delivered for transdermal drug delivery. We also showed that the viable epidermis serves 
as an important barrier for molecule transport. For the sulforhodamine B study in full thickness 
skin, without a mask, sulforhodamine B penetrated the entire dermis within six hours for the 
samples in which the stratum corneum was completely abraded (-45 kPa for 50 passes). In the 
case of the settings with 10 passes, where the SC was partially removed, sulforhodamine B 
penetrated the skin but the penetration and flux were significantly lower than the samples with 
complete sulforhodamine B removal. These results show that partially removing the 
sulforhodamine B increases the skin’s permeability, but maximum drug delivery is achieved 
when the sulforhodamine B is completely removed.  
 Due to the molecular weight of Texas Red bovine serum, all the sulforhodamine B was 
removed during the delivery experiments. The skin was abraded without the use of a mask. 
Texas Red bovine serum penetrated the abraded skin, but did not diffuse into the untreated 
control skin. There also was a significant time lag in the rate of diffusion and the fluorescence 
intensity did not change between the 6 and 24 hour sample. Compared to sulforhodamine B, 
Texas Red bovine serum was mostly localized in the viable epidermis. This is likely due to the 
basal lamina, located between the viable epidermis and dermis, which serves as a barrier to 
compounds larger than 40 kDa [62]. This barrier dramatically slowed down the diffusion of 
Texas Red bovine serum and resulted in it penetrating the dermis only in the 6 and 24 hour 
experiments. Also due its large molecular weight, Texas Red bovine serum did completely 
diffuse across the entire dermis, but it reached the site of the systemic circulation 
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(epidermis/dermis junction). Proteins that are delivered using microdermabrasion may be 
beneficial for treating skin diseases in the viable epidermis and superficial dermis. 
The influenza delivery results were similar to Texas Red bovine serum. The penetration 
of the vaccine occurred between 6 and 24 hours. The delivery time was due to the large 
molecular weight of the virus. Also the virus was inactivated, so the delivery relied primarily on 
diffusion. Vaccine delivery was examined because studies have found that delivering vaccines to 
the epidermis can illicit a greater immune response than traditional routes [63]. This is due to the 
large number of dendritic and Langerhan’s cells that are found in the viable epidermis and 
dermis. These cells are first line of defense in protecting the body against infection when the skin 
is breached [63]. Many vaccines for tuberculosis and small pox are delivered into the viable 
epidermis and dermis [11]. 
Using a mask in conjunction with abrading the skin allowed better three dimensional 
control of the abrasion site. The mask experiments were carried out in split thickness skin 
because it was determined in preliminary experiments that the concentration of the molecules 
could not be measured. Removing the viable epidermis resulted in ten fold increase the 
penetration of sulforhodamine B and insulin. Decreasing the skin thickness also significantly 
decreased the delivery lag time. Compared to the full thickness skin the split thickness skin was 
three times higher than the full thickness skin. This is due to the fact that all of the subcutaneous 
fat was not completely removed from the dermis and this created an additional barrier. Also, 
there was a large variability in the skin thickness, the full thickness skin was 3.5 mm and the split 
thickness skin was 500 µm. 
 The delivery of the drugs relied primarily on diffusion. The lower molecular weight drug 
was able to diffusion faster than the protein and vaccine. The depth of abrasion was an important 
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parameter that determined the penetration of drugs. Although we showed that you can deliver a 
range of compounds using microdermabrasion, other factors such as dose and application time 
should be considered for administering drugs using microdermabrasion. Large molecular weight 
drugs are probably impractical to deliver due to the long diffusion time. Future experiments will 
be conducted to determine the efficacy of proteins that are administered using 





















TRANSDERMAL INSULIN DELIVERY USING MICRODERMABRASION 
 
Diabetes mellitus is a metabolic disorder that is characterized by the lack of insulin 
production or insulin resistance. Traditionally diabetes is treated by administering insulin with a 
subcutaneous injection or by an insulin pump. This study investigates the use of 
microdermabrasion, a non-invasive cosmetic skin resurfacing technique, as a method to 
administer insulin to diabetic rats. Thirty-nine rats were injected with streptozocin to induce 
diabetes. The rats were abraded through a polymer mask to control the area of abrasion with 
conditions that removed the stratum corneum and viable epidermis. After abrasion, an insulin-
filled patch was placed on the area of abrasion and insulin was delivered for four hours and the 
blood glucose was monitored for eight hours. The maximum blood glucose decrease for the rats 
with stratum corneum removal was 48 mg/dL at 6 h after abrasion. However, removing the 
viable epidermis resulted in a maximum blood decrease of 147 mg/dL at 4 h after abrasion. The 
peak concentration of insulin that was detected in the blood serum of the stratum corneum and 







respectively. The depth of abrasion was the most significant factor on the rate of insulin delivery. 
Microdermabrasion can be used as a transdermal drug method for administering insulin and can 
significantly lower the blood glucose levels.  
Introduction 
Diabetes mellitus is a metabolic disorder that is characterized by the lack of insulin 
production (Type I) or insulin resistance (Type II) [64, 65]. Insulin is a protein that is produced 
by the beta cells in the pancreas and it functions to allow cells to transport glucose from the 
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blood. People who suffer from Type I diabetes, also known as juvenile diabetes, do not produce 
insulin due to autoimmune destruction of the beta cells [65]. Type I patients are insulin 
dependant and require frequent daily insulin injections to regulate blood glucose levels. Type II 
diabetes, also known as adult onset diabetes, is caused by insulin resistance and is often 
attributed to obesity [64, 66]. Typically, patients can avoid becoming insulin dependant by taking 
medication and making lifestyle changes [64]. In 2010, it was estimated that were 150 million 
people in the world who suffer from diabetes [64]. 
Traditionally diabetes is treating by measuring the blood glucose and administering 
insulin with a subcutaneous injection or an insulin pump. The insulin pump is a delivery device 
that is programmed by the user to administer the proper insulin dose through a catheter 
implanted in the skin. Although these delivery routes are the most common and effective 
methods of delivering insulin, there are several drawbacks to using syringes and pumps. Needle-
phobia, pain, regulated waste disposal, cost, and needle stick injuries are disadvantages to 
traditional diabetes treatment. These disadvantages have lead to the discovery of less invasive 
methods for treating diabetes to the reduce use of hypodermic needles.  
 Several new delivery methods and devices, such as inhalation and microneedles, 
have been designed to treat diabetes and resolve the issues associated with using hypodermic 
needles.  Inhalable insulin formulations are designed to eliminate injections and deliver insulin 
into the bloodstream through the lung mucosa. One such pharmaceutical product is Exubera®, 
which was approved by the FDA in 2006. However, due to its side effects it was later withdrawn 
from the market [67].  Microneedles are micro-size needles that can be used to deliver insulin 
either in conjunction with a patch or by infusion [18, 58]. One published study used solid 
microneedle in conjunction with a insulin reservoir to successfully lower the blood glucose in 
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diabetic rats [58]. Another study used hollow microneedle to infuse insulin to diabetic human 
subjects [60]. The study lowered the patients’ blood glucose and it also reported that the subjects 
did not report pain, which would increase patient compliance.  
Another method of administering insulin is microdermabrasion, a superficial cosmetic 
resurfacing technique that removes the skin’s layers by bombarding them with pressurized 
particles [14, 15]. Traditionally, microdermabrasion is used to lessen the appearance of fine 
lines, wrinkles, and scars [15, 56]. In recent years, microdermabrasion has been used as a method 
of disrupting the stratum corneum for transdermal drug delivery [1, 7, 8, 12, 13]. This study 
investigated the use of microdermabrasion, in conjunction with a polymer mask, as a method of 
delivering insulin to diabetic rats.  
Results 
We wanted to determine if microdermabrasion can deliver a therapeutic dose of insulin 
and if the depth of abrasion had an affect on the rate of insulin delivery. The cumulative blood 
glucose change for all the groups are shown in Figure 25. Only the animals that survived the 
entire experiment and met the diabetes induction criteria were used for the blood glucose and 
insulin quantification analysis. The negative control group maintained high blood glucose values 
throughout the experiment. The positive control animals were used to estimate the amount of 
insulin that was delivered using microdermabrasion. The positive control animals received a 
bolus injection of 0.1 U of insulin and exhibited a 63 ± 24 point decrease in blood glucose levels 
within 30 min of administration. However, the blood glucose returned to hyperglycemic levels 
(i.e.,>250 mg/dL) after 4 h. By the conclusion (i.e.,after 8 h) of the experiment, the subcutaneous 




Figure 25. The cumulative change in the blood glucose levels for all the experimental groups are shown in the 
graph. The negative control rats (♦) were not abraded or given insulin. The rats that were injected with 0.1 U of 
Humalog  (■). The stratum corneum (▲) and viable epidermis (●) abrasion groups were administered 200 µL of a 
solution containing 80% U100 Humalog and 20% FITC-labeled bovine insulin, via a transdermal patch, at the 
abrasion site. The standard deviation for all the groups ranged from 18 to 94 mg/dL. 
Shown in Table 1 is the time to the lowest blood glucose value (tmax, glucose) and 
maximum blood glucose reduction (Cmax, glucose), and area under the curve (AUC) for the blood 
glucose versus time graph for all the animals that were administered insulin. The positive control 
achieved a peak blood glucose reduction of 157 mg/dL after 1.5 hr and then gradually returned to 
baseline values over the remaining 6.5 h. The total area under the curve of the blood glucose 
curve was 889. The stratum corneum removal group maximum blood glucose reduction of 48.2 
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after 6 h and then gradually returned to baseline values over the remaining 2 h. The total area 
under the curve of the blood glucose curve for the stratum corneum group was 215. The viable 
epidermis removal group maximum blood glucose of 146 after 4 h and the blood glucose 
gradually increased over the remaining 4 h. The total area under the curve of the blood glucose 
curve for the viable epidermis group was 805. Removing viable epidermis resulted in a shorter 
delivery lag time and a greater blood glucose decrease than the stratum corneum removal group. 
The negative control rats maintained stable hypoglycemic blood glucose values throughout the 
experiment. The maximum blood glucose decrease for the negative control was 9 mg/dL after 4 
h.  
Table 1. The time to the maximum blood glucose reading (tmax), maximum blood glucose 
decrease (Cmax) and the area under the blood glucose curves shown in Figure 25 are shown in the 
table.  
 
Group (tmax, glucose)  hr (Cmax, glucose) mg/dL 
Area under curve 
(AUCglucose) 
Positive control (0.1 U 
insulin) 1.5 157 889 
Stratum corneum removal 6 48.2 215 
Viable epidermis removal 4 146 805 
 
The standard deviation for the blood glucose graph ranged from 18 to 93 mg/dL. The 
large deviation was probably due to large variability in the blood glucose values and the animals’ 
response to the insulin. The animals were given the same dose of streptozocin and there was a 
large variability in the blood glucose. There was no way to predict the resulting effect of 
streptozocin exposure. The rats also responded differently to the Humalog. Rats with high blood 
glucose (>400 mg/dL) responded slower to the insulin, including those that were administered 
the bolus injection, compared to the rats with lower blood glucose values (<400 mg/dL). These 
results caused a large standard deviation for some of the groups.  
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The streptozocin administration protocol resulted in 100% induction of diabetes in all the 
rats. However, the blood glucose was highly variable among the rats and ranged from 313 to 450 
mg/dL. The initial the blood glucose values before streptozocin exposure ranged from 113 to 165 
mg/dL. The animals were under terminal anesthesia for the entire experiment and this may have 
also contributed to hyperglycemic blood glucose levels. The high blood glucose levels and 
prolonged anesthesia led to the death of four rats. In a two cases, the blood glucose exceeded 475 
mg/dL and animals were euthanized. 
The total concentration of insulin that was delivered was quantified by ELISA and the 
results are shown in (Figure 26). The delivered concentration was determined by subtracting the 
insulin concentration at 0 h, before insulin administration, from all the time points. Shown in 
Table 2 is the time to the highest serum insulin value (tmax, insulin) and maximum insulin 
concentration (Cmax, insulin), and area under the curve (AUC) of the insulin concentration versus 
time graph for all the animals that were administered insulin. The measured insulin concentration 
is the sum of the endogenous rat insulin and the delivered Humalog-R. The positive control 
maximum serum insulin concentration of 0.37 ng/mL (1.4x10
-8
 U/mL) peaked at 30 min and the 
insulin concentration decreased for the remainder of the experiment. The area under the curve for 
serum insulin levels for the positive control was 0.45. The stratum corneum removal group 
maximum serum insulin concentration of 0.18 ng/mL (6.7x10
-9
 U/mL) peaked at 4 h and 
declined for the remainder of the experiment. The area under the curve was 0.69. The viable 
epidermis group maximum serum insulin concentration of 0.74 ng/mL (2.8x10
-8 
U/mL) peaked 
at 2 h. The area under the curve was 2.62. The negative control rats were untreated and 
maintained low serum insulin levels. This result correlated with the negative control’s 
hyperglycemic blood glucose behavior throughout the experiment. Using one way ANOVA, it 
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was determined that the positive control group was significantly different (p<0.05) than the 
negative control and the stratum corneum groups, but not the viable epidermis group (p>0.05). 
The stratum corneum group serum insulin levels was significantly different than all the other 
groups (p<0.05). The viable epidermis group was significantly different that the negative control 
and stratum corneum group (p<0.05), but not positive control group (p>0.05).  
 
Figure 26. Shown in the graph is the serum insulin concentration that was determined by ELISA. The negative 
control (●) rats had the lowest insulin levels. The positive control (♦) insulin levels peaked at 30 min and declined 
for the remainder of the experiment. The stratum corneum group (■) insulin levels peaked at hour 4, but were lower 
than the viable epidermis and positive control groups. The viable epidermis group (▲) had the highest insulin level 
from hours 1 to 6. The standard deviation for the groups ranged from 0.08 to 0.75 ng/mL. 
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Table 2. The time to the maximum insulin concentration (tmax), maximum insulin concentration 
(Cmax) and the area under the insulin concentration curves shown in Figure 26 are shown in the 
table. 
 
Group (tmax, insulin) hr (Cmax, insulin) ng/mL 
Area under curve 
(AUCinsulin) 
Positive control (0.1 U 
insulin) 0.5 0.37 0.45 
Stratum corneum removal 4 0.18 0.69 
Viable epidermis removal 2 0.74 2.62 
 
 We wanted to visualize the depth of the insulin penetration in the abraded skin. FITC-
labeled bovine insulin was mixed with the Humalog in the transdermal patch and applied to the 
site of abrasion. The abrasion histology results from the experiment are shown in Figure 27. The 
pictures on the top row are the gross pictures of the negative control (Figure 27A) and abraded 
skin (Figure 27B) where the area of abrasion was revealed with green dye. The pictures on the 
middle row are fluorescence images of the FITC-labeled bovine insulin of the skin after 
sectioning. The stratum corneum abrasion (Figure 27C) and viable epidermis abrasion (Figure 
27D) skin both had penetration of the FITC-labeled bovine insulin. Most of the fluorescence was 
concentrated near the skin’s surface. The penetration of the FITC-insulin was viable epidermis 
was more extensive than the stratum corneum group. The bottom row consists of the 
hematoxylin and eosin stained images of stratum corneum group (Figure 27E) and the viable 
epidermis group (Figure 27F). The stratum corneum, the upper most layer, is stained pink and is 
removed in Figure 27E. The viable epidermis, located directly beneath the stratum corneum, has 
blue stained cell nuclei and remained intact. Shown in Figure 27F is skin that had the viable 
epidermis removed. The pink staining in the viable epidermis is indicative of the skin healing 




Figure 27. The histology pictures for insulin delivery in hairless rats using microdermabrasion. The control skin (A) 
was not abraded and the area of abrasion for the microdermabrasion-treated skin (B) was revealed with green dye. 
The fluorescent images of the diffusion of FITC-labeled bovine insulin in the skin with stratum corneum (C) and 
viable epidermis removal (D) are shown on the middle row. The H&E stained images for the stratum corneum (E) 
and viable epidermis abrasion (F) skin are shown on the last row. The extent of the abrasion damage has decreased 
due to healing.  
Discussion 
In this study we wanted to determine if microdermabrasion could be used to deliver a 
therapeutic dose of insulin to significantly decrease the blood glucose in diabetic rats. Removing 
the stratum corneum resulted in an increased permeability to insulin and a peak blood glucose 
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decrease of 48 mg/dL at 6 h for the stratum corneum removal group. The abrasion group with 
viable epidermis removal exhibited a 146 mg/dL peak blood glucose decrease at 4 h after 
abrasion. Both abrasion groups’ blood glucose behavior was significantly different (p<0.05) than 
the untreated control. Based on the results, we showed that microdermabrasion can be used as a 
method for significantly reducing the blood glucose in diabetic animals. 
We also wanted to examine the affect of the depth of abrasion on the rate of insulin 
transport by removing the stratum corneum and the viable epidermis. Removing only the stratum 
corneum resulted in a decrease in the rats’ blood glucose. The largest decrease in the blood 
glucose over the duration of the experiment was 48 mg/dL at 6 h. Animals that had severe 
hypoglycemia (>400 mg/dL) exhibited the smallest decrease in their blood glucose levels. Using 
a one-way ANOVA (p=0.05), it was determined that stratum corneum blood glucose decrease 
was significantly different than the all the other groups (p<0.05). The animals in the stratum 
corneum group also had a longer insulin diffusion lag time, two hours, as compared to the viable 
epidermis removal group. The peak insulin value for the stratum corneum group was 0.51 ng/mL 
(1.77x10
-8 
U/mL) at 4 h and it was lower than the viable epidermis removal group. The serum 
insulin values for the stratum corneum removal group was significantly different that the 
negative control and viable epidermis group (p<0). 
Removing the viable epidermis resulted in the blood glucose decreasing immediately 
after insulin exposure and that trend continued until the insulin patch was removed at 4 h. 
Similar to the other rat groups, the viable epidermis abrasion rats had initial blood glucose 
readings in excess of 300 mg/dL. Removing the viable epidermis reduced the insulin delivery lag 
time to 30 min and the blood glucose decreased as much as 13 times more than the stratum 
corneum removal group. The time to reach the maximum decrease in the blood glucose for the 
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viable epidermis group was 4 h as compared to 6 h for the stratum corneum group. The area 
under the blood glucose for the viable epidermis was 805, as compared to the stratum corneum 
group curve area of 215. These results showed that the viable epidermis serves as an important 
barrier to insulin diffusion. Using a one-way ANOVA (p=0.05), it was determined that the viable 
epidermis blood glucose decrease was significantly different than the negative control and 
stratum corneum group (p<0.05), but was not different than the positive control that received the 
subcutaneous injection (p>0.05). The viable epidermis serum insulin peak concentration was 
1.03 ng/mL (3.58x10
-8
 U/mL) at 2 h. The value was twice as much as the stratum corneum group 
and the concentration peaked 2 h sooner.  
 Most transdermal drug delivery techniques, such as tape stripping and iontophoresis, are 
focused on removing, altering, or disrupting the stratum corneum since it serves as an important 
barrier to the penetration of drugs [1]. The stratum corneum prevents the penetration of water 
soluble molecules and large molecular weight compounds (>500 g/mol) into the skin. There are 
few technologies that focus on the viable epidermis for drug delivery.  However, the viable 
epidermis also contributes to the skin’s barrier properties and serves as another rate limiting step 
in the diffusion of molecules. The viable epidermis is composed of viable keratinocytes that 
undergo the process of cornification to become stratum corneum cells [24]. The viable epidermis 
is 70% water and similar to the stratum corneum it is not vascularized. At the base of the viable 
epidermis is basal lamina, which provides the viable epidermis barrier properties. 
The basal lamina, located between the epidermis and dermis, serves a semi-permeable 
membrane between the two skin layers to control cell movement [17]. It is mainly composed of 
type IV collagen and proteoglycans that provide an anchoring point for epidermal basal cells and 
controls movement of substances across membrane [26]. It is thought that the basal lamina 
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restricts the movement of molecules that are larger than 40 kDa [17]. Although insulin has a 
molecular weight around 4 kDa, the viable epidermis seemed to serve as a barrier and resulted in 
a higher diffusion of insulin when it was removed.  
 Since microdermabrasion relies on diffusion to deliver insulin it has the potential to be 
developed into a method for delivering basal doses of insulin to diabetic patients. The abrasion 
depth and insulin concentration can be adjusted for the patient’s dosage. Microdermabrasion is 
non-invasive, painless, and does not result in scars. Similar to a transdermal patch, the insulin 
delivery can be halted by removing the patch. Rather than using a liquid-filled patch, a solid state 
insulin formulation patch could be developed. The patch can also contain excipients that 
decrease the rate of skin healing to maximize delivery time.  A portable microdermabrasion 
device can be developed that will allow patients to self administer controlled abrasion and apply 
the insulin patch without the assistance of medical personnel. Using this technology to 
administer insulin could result in higher patient compliance since it does require the use of 












SKIN REPAIR KINETICS AFTER STRATUM CORNEUM REMOVAL USING 
MICRODERMABRASION IN HAIRLESS GUINEA PIGS 
 
 This study examined the kinetics of skin repair after complete removal of the stratum 
corneum using microdermabrasion in hairless guinea pigs. Microdermabrasion is a minimally 
invasive cosmetic technique that can be used to remove the stratum corneum. The skin was 
abraded at two sites using conditions that completely removed the stratum corneum. One site 
was occluded with an electrode and occlusive tape and the other site remained non-occluded. 
The rate of barrier recovery was assessed using electrical resistance measurement and histology. 
The baseline resistance was measured 1 h, 2 h, and 1 min prior to the experiment. The resistance 
for the experiment was monitored one minute, 4 h, 12 h, and 24 h after abrasion. The resistance 
for both types of wound coverings decreased after abrasion and the non-occlusive coverings 
increased throughout the experiment. The occlusive covering skin resistance continued to 
decrease throughout the experiment and was significantly different than the negative control and 
non-occluded skin. It was determined that abraded skin was significantly different than the 
negative control, but there was no difference between the wound coverings. Sulforhodamine B, a 
water soluble dye was used to determine if the stratum corneum had recovered and if its barrier 
was functional. At the conclusion of the experiment, the skin was sectioned and stained to 
visualize the skin’s structure. Based on the histology and a dye penetration test, the barrier had 
reformed and was functional within 12 hours for both coverings. Transdermal drug delivery after 
microdermabrasion is limited up to 12 hours in guinea pigs; however, humans will probably have 




 The skin is a semi-permeable barrier that protects the body from the external environment 
and prevents water loss. The stratum corneum, the upper 10-15 µm, serves as the skin’s primary 
barrier and is composed of non-viable cornocytes that are surrounded by a lipid extracellular 
matrix [1]. Due to its structure only low molecular weight (<500 Da) lipophilic molecules can 
diffuse across intact skin. Water soluble molecules and molecules larger than 500 Da have 
limited diffusion across intact skin [1]. Due to the stratum corneum selectivity, most 
pharmaceuticals cannot be administered in a transdermal patch formulation. Several methods 
such as tape stripping, microneedles, chemical enhancers, electroporation, thermal ablation, and 
microdermabrasion have been developed to disrupt or remove stratum corneum and increase the 
skin’s permeability to large molecular weight and water soluble molecules for transdermal drug 
delivery [1, 9, 51, 68]. Transdermal drug delivery is an attractive route of administration due to 
the ease of applying patches and ointments, the drugs avoid degradation by the liver, and does 
not require the use of hypodermic needles [1].  
One transdermal method that is used to remove the stratum corneum is 
microdermabrasion. Microdermabrasion is a cosmetic procedure that improves the appearance of 
superficial skin defects such as fine lines, wrinkles, and scars by abrading the stratum corneum 
with pressurized particles [13, 14, 28, 55, 57, 69]. The depth of abrasion depends on the severity 
of the patient’s skin, but in a clinical setting the stratum corneum is not usually completely 
removed [28]. Microdermabrasion was initially designed for cosmetic applications, but it has 
been used in several studies for delivery of low molecular weight hydrophilic molecules and 
vaccines [7, 8, 12, 13]. Although previous studies have been successful in completely removing 
the stratum corneum using microdermabrasion, the recovery of the barrier after complete 
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removal has yet to be examined. A previous study was conducted to study barrier recovery in 
humans after microdermabrasion treatment using transepidermal water loss and it was shown 
that the barrier recovered one day after treatment [54]. It was not indicated if the stratum 
corneum was completely removed. Other studies examined the recovery of the stratum corneum 
after complete removal with extensive tape stripping. In one such study, tape stripping was 
performed on pigs and the stratum corneum recovered within two weeks [70]. The study 
examined the recovery of the stratum corneum layer using histology, but it did not examine any 
time points between 30 min and 14 days after stripping, so the actual time of recovery is not 
known. Other studies have examined stratum corneum barrier recovery after tape stripping skin 
that was affected by diseases that resulted in impaired stratum corneum function [71]. While 
those studies provide useful information, there is a need to measure the rate of stratum corneum 
recovery after complete removal with microdermabrasion for safety and for determining amount 
of time drugs can be delivered across abraded skin. The goal of this study is to investigate the 
kinetics of skin resealing after complete removal of stratum corneum using microdermabrasion 
in hairless guinea pigs. We will also examine the affect wound coverings on the kinetics of 
stratum corneum recovery.  
Skin healing has been extensively studied and characterized in order to understand the 
response to injury and pathologies that prevent and delay healing. After injury, the skin heals in 
three phases: inflammation, reepithelialization, and tissue remodeling [43, 72].  The 
inflammation phase occurs within a few minutes after injury and involves activation of 
neutrophils and the release of cytokines and growth factors that stimulate fibroblast proliferation 
and attract circulating monocytes to the injury site [43]. Reepithialization occurs within hours 
after injury and during the phase the stem cells in the basement membrane proliferate to repair 
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the damaged area and cells from appendages migrate to the injury site [41, 43].  Organisms that 
have a high density of appendages, such as rodents, exhibit a more rapid healing response to 
injury [44, 73]. The final step of healing is tissue remodeling, where collagen is altered to 
remodel the skin back to its natural form and function. Healing of superficial wounds, such as 
microdermabrasion, is expected to undergo this healing process, but at a more rapid rate than 
deep wounds.  
The rate of wound healing is affected by severity of the injury and also by the type of 
dressing that is used.  In a study conducted on humans and pigs, occlusive dressings were shown 
to accelerate the rate of reepithialization and prevent the formation of scabs [45].  However, 
occlusion can also delay the formation of functional stratum corneum after injury [46]. Non-
occlusive wounds tend to form scabs during the healing process [45]. Semi-occlusive coverings 
have been found to promote healing more effectively than occlusive and non-occlusive 
membranes in tape stripped skin [47].  
 Several methods can be used to measure the rate of recovery and functionality of the 
stratum corneum. One method is histology, which involves sectioning and staining the skin to 
visualize the layers. Though it can provide useful structural information, it is a destructive 
technique that requires trained personnel for sectioning and tissue collection, it can be expensive, 
and is time consuming. Electrical resistance can be used to monitor the skin’s integrity non-
invasively by measuring the skin impedance [74]. The resistance value of intact skin is higher 
than when the stratum corneum is breached. The behavior of the skin’s impedance can be used to 
determine the kinetics of recovery. Exposing the skin to hydrophilic dyes is another method of 
determining the integrity of the stratum corneum. Dyes can be applied to the skin to stain and 
diffuse into sites where the stratum corneum is compromised. The dye will not stain or penetrate 
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areas in which the stratum corneum is intact since water soluble molecules do not readily diffuse 
into stratum corneum. Dye tests are rapid and inexpensive for characterizing the skin surface, but 
histology is needed to quantify the depth of penetration. This study investigated the effect of 
wound coverings on recovery and integrity of the stratum corneum after complete removal using 




 We wanted to study the kinetics of stratum corneum recovery after complete removal 
using microdermabrasion by quantifying skin impedance behavior over the course of the study. 
The resistance for the abraded skin over the course of the 24 h experiment is shown in Figure 28. 
The negative control was not treated and maintained a constant resistance value throughout the 
experiment. The resistance at each time point was not significant (ANOVA, p>0.05). The 
negative control was significantly different than the both types of wound coverings (ANOVA, 
P<0.05) for all time points. The occluded sample resistance remained unchanged for the full 24 h 
after abrasion and was not significant for all time points (ANOVA, p>0.05). At the conclusion of 
the experiment (24 h), the initial resistance for the occluded covering was less than that the initial 
pre-abrasion values and the negative control (Student’s t-test, p<0.05). The non-occluded skin 
covering increased after abrasion and the resistance was at all time points was significant 
(ANOVA, p<0.05).  The non-occluded covering 24 h resistance values was not significantly 
different than the original pre-abrasion values (Student’s t-test, p>0.05). The wound coverings 
were also determined to be significantly different for all time points (ANOVA, P<0.05). The 
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resistance for the sham skin (not pictured) was measured before and after treatment with the 
microdermabrasion tip. The sham skin resistance decreased after treatment, but were not 
significant from the negative control (ANOVA, p>0.05).  
 
Figure 28. The graph shows the resistance measurements for the skin coverings over 24 h. The negative control (♦) 
skin maintained high resistance level throughout the experiment. The occluded (■) and non-occluded (▲) skin 
decreased immediately after abrasion (time>0). The non-occluded sample resistance increased after abrasion. The 
occluded sample resistance continued to decrease after abrasion and maintained a constant resistance. Neither 
wound coverings reached their initial pre-abrasion resistance values. Each point is an average of 4 replicates and the 







 We first wanted to examine the effect of abrading the skin without crystals and pressure 
on the skin resistance (i.e., sham). Two animals were abraded at two sites for 10 passes (1 pass/s) 
using the MDA tip. An additional site on each animal was used as a negative control and was not 
abraded. After treatment, sulforhodamine was applied to the sham and negative control skin to 
determine if there was penetration of the dye due to breached stratum corneum. Representative 
histology pictures for the sham skin are shown in Figure 29. The H&E stained sections are 
shown on the left and the fluorescent pictures that illustrate sulforhodamine B penetration as a 
result of the breached barrier are shown on the right. The negative control skin was not treated 
and the skin layers can be seen in Figure 29a1. The stratum corneum is stained pink, the blue-
stained nuclei of the viable epidermis are seen below, and the pink-stained dermis is deeper still. 
The sulforhodamine did not penetrate into the skin (Figure 29a2). The abrasion area did not 
result in stratum corneum removal (Figure 2b1) or sulforhodamine penetration (Figure 29c1). 
The sham experiments were performed after euthanasia, so the effect of occlusion or non-




Figure 29. The histology results of the sham experiment are shown above: negative control (NC) and the sham site 
(Sham). The H&E and fluorescent stained skin are shown on the left and right, respectively. The sham site was 
abraded for 10 passes (1 pass/s), without crystals or pressure. All the skin layers were intact for both the skin 
samples.  
Occluded Skin  
We wanted to further understand the kinetics of skin resealing, after microdermabrasion, 
by examining the effect of occlusive dressings. The skin was abraded at a suction pressure of -40 
kPa for 10 passes and half of the maximum crystal flow rate. After abrasion mild erythema was 
observed and at the conclusion of the experiment the skin was slightly erythemic. The 
representative pictures for the skin occluded for 0, 4, 12, and 24 hours are shown in Figure 30. 
The H&E–stained images are shown on the left and the sulforhodamine B fluorescent pictures 
are shown on the right. The untreated negative control skin was not abraded, so the stratum 
corneum remained intact as indicated by the presence of the pink-stained stratum corneum atop 
the viable epidermis containing blue-stained nuclei in the H&E image (Figure 30a1). The stratum 
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corneum prevented the sulforhodamine B from penetrating the skin as shown in the fluorescent 
image (Figure 30a2). The samples immediately after abrasion had complete stratum corneum 
removal, and indicated by the lack of pink-stained tissue atop the viable epidermis (Figure 30b1) 
and sulforhodamine B (Figure 30b2) penetrated deeply within the skin. The stratum corneum had 
not recovered in the four hour skin (Figure 30c1) and sulforhodamine B again penetrated deeply 
into the skin (Figure 30c2). The four hour skin also exhibited signs of inflammation as indicated 
by the increased number of blue stained cells, which are believed to be inflammatory cells. The 
characteristic dermal – epidermal junction was also difficult to see. In the 12 and 24 hour 
samples, the stratum corneum barrier had recovered as indicated by the return of pink-stained 
tissue atop the viable epidermis (Figure 30d1 and e1) and the inability of sulforhodamine to 




Figure 30. Shown above are the pictures of the occluded experiment skin sections. The pictures on the right are the 
H&E stained pictures and the left are the sulforhodamine fluorescent pictures. The time points for the pictures is 




We also wanted to observe the kinetics of stratum corneum barrier recovery without 
occlusion after microdermabrasion.  Mild erythema was initially observed, but it resolved within 
24 h. The representative pictures for the skin that was abraded and healed without an occlusive 
covering are shown in Figure 31. Similar to the occluded samples, the H&E pictures are shown 
on the left and the sulforhodamine B fluorescent pictures are shown on the right. The stratum 
corneum was intact on the untreated negative control skin (Figure 31a1) and the sulforhodamine 
B did not diffuse into the skin (Figure 31a2). The stratum corneum was completely removed in 
the skin samples immediately after abrasion (Figure 31b1) and sulforhodamine B penetrated into 
the skin (Figure 31b2). The stratum corneum was not present in the four hour skin (Figure 31c1). 
Similar to the four hour occluded sample, the dermal-epidermal was indistinguishable. Both 
layers had a large number of blue stained cells, suggesting inflammation. Sulforhodamine 
diffused deeply into the skin for the four hour group (Figure 31c2). The stratum corneum was 
present in the 12 and 24 hour groups and was seen in the H&E images (Figure 31d1 and e1) and 




Figure 31. Shown above are the pictures of the non-occluded experiment skin sections. The pictures on the right are 
the H&E stained pictures and the left are the sulforhodamine fluorescent pictures. The time point for each picture is 




This study measured the kinetics of the stratum corneum recovery after removal using 
microdermabrasion. The rate of recovery was studied using skin electrical resistance, histological 
imaging, and dye penetration. Immediately after abrasion, the electrical measurements for the 
occluded and non-occluded both wound coverings decreased 1271 ±14 and 1702 ±16 kΩ*cm
2
, 
respectively.  The resistance for the occluded skin remained constant during the experiment and 
the resistance for each time point was not significant (Student’s t test, p>0.05). The occluded 
skin resistance was lower than the negative control and non-occluded skin for all time points 
(ANOVA, p<0.05). At 24 h, the final resistance value was significantly different than the initial 
resistance value, indicating the stratum corneum was not reformed (Student’s t test, p<0.05). The 
resistance for the non-occluded skin increased throughout the experiment and all the time points 
were significantly different (ANOVA, p<0.05). The rate of recovery of the stratum corneum 
recovery in the non-occluded sample and was significantly different than the negative control 
and the occluded sample for all time points (ANOVA, p<0.05). At 24 h, the final resistance value 
for the occluded skin was not significantly different than the initial resistance value indicating 
the skin was partially or completely reformed (Student’s t test, p>0.05). 
Based on the resistance data, the non-occluded sample healed at higher rate than the 
occluded sample. However, these results do not agree with the histology data. Both samples had 
reformed and functional stratum corneum within 12 hours. One reason for this discrepancy may 
be due to the collection of interstitial fluid under the occluded skin dressings that may have 
caused a lower resistance value. The ability of the ions to transverse breached or partially intact 
stratum corneum more readily than sulforhodamine, because of their low molecular weight, may 
have also contributed to a higher electrical current and lower resistance values. Another 
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consideration is that the negative control for the experiment was non-occluded for the duration of 
the experiment.  Comparing the occluded site to an occluded negative control site would have 
given a better estimate of the change in resistance as a function of time.  
Based on the histological results, there was no difference in healing between the two 
types of wound covering. At four hours after abrasion the viable epidermis and dermis were 
infiltrated by a large number of cells. This observation was seen in both wound coverings. Those 
cells were not selectively stained to distinguish between them. The barrier was not reformed and 
layers of the skin were difficult to distinguish. In both cases, barrier reformed between 4 and 12 
hours and was functional based on the results of the dye test. Both types of wound coverings 
exhibited a large number of cells in the viable epidermis and dermis four hours after abrasion and 
the response was significantly less noticeable by 12 hours. At 12 and 24 hours the skin layers 
were reformed and the number of cells in the epidermis had decreased.   
 Sulforhodamine B, was applied to test the functionality of the recovered stratum corneum 
because it does not readily penetrate intact skin as shown in the fluorescent picture of the 
negative control skin. At 4 h, both coverings resistance were significantly different that the 
negative control (Student’s test, p<0.05) and the dye diffused into the skin due to the breached 
barrier. Based on the sulforhodamine B dye penetration test we found that the skin resealed and 
was functional within 12 h for both wound coverings. The dye penetration data at 12 and 24 h 
correlates with the electrical resistance data for the non-occluded sample, but not the occluded 
sample. This is probably due to the accumulation of interstitial fluid that may have decreased the 
resistance readings in the occluded skin.  
 While guinea pigs were used for this study because they are easy to house and handle and 
their skin is an acceptable model for human skin, they may not be the best model for healing. 
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The rapid stratum corneum recovery that was observed in this study will probably not occur in 
humans due to the small density of hair follicles and the inability to heal wounds as rapidly as 
guinea pigs. During the process of healing, cells from the hair follicles migrate to the site of 
injury to repair the wound [73]. Guinea pigs have a high density of hair follicles which allowed 
the skin to heal at a faster rate [44, 73]. It has also been shown that rodents can  heal centimeter-
size skin wounds within 10 days, which cannot be accomplished by a human without medical 
intervention [44].  
 Several studies have investigated the recovery of the stratum corneum after disruption 
with microdermabrasion, chemical treatment, and microneedles. The skin has been shown to heal 
within between 1 to 2 days following microdermabrasion treatment, with no occlusion, in 
humans as measured by transepidermal water loss measurements [54, 75]. The 
microdermabrasion pressure used for the experiment was higher than used for this study, but 
there was no indication of exposure time and the degree of stratum corneum removal. The 
stratum corneum recovered more rapidly in this study (12 hours), but this was probably due to 
the animal model and the small area of stratum corneum removal. Barrier recovery after 
exposure to chemical peels and acetone was reported after 3 days [54, 76]. The skin was not 
occluded for the study and was measured using transepidermal water loss measurements. 
Wounds created from microneedles, which pierce into the superficial dermis, in humans has been 
shown to heal within 15 min after injury [76]. Although many transdermal methods can result in 
rapid healing of the skin, but stratum corneum recovery is mostly dependent on the extent of the 
skin damage and the animal model that is used.  The time in which the skin heals also impacts 
the type of drugs that can be administered for transdermal drug delivery. Small molecular weight 
drugs can diffuse more readily across breached skin than large proteins. They can be delivered in 
96 
 
systems in which the skin reseals quickly. Larger molecules, such as vaccines and proteins, may 
require more extensive skin damage, excipients, or coverings that will decrease the rate of 
healing.  
From a safety standpoint the rapid resealing will lower the risk of infections, but it 
presents a complication for transdermal drug delivery since the time for drug diffusion maybe be 
short. This study determined that skin healed in guinea pig within 12 h, however we expect the 
delivery time will be longer in humans. Based on studies that examined skin resealing with 
occlusion and non-occlusion after microneedle insertion in humans and guinea pigs, it was 
shown that non-occluded human skin resealed within 2 h and the occluded guinea pig skin 
resealed after 72 h [77]. Using these studies as a model, we expect the drug delivery time for 
human skin treated with microdermabrasion to be longer than microneedles since a larger area of 
skin is removed. Additional studies will have to be conducted to determine the kinetics of 
stratum corneum recovery of occluded and non-occluded skin in human subjects after 











Chapter 8: Conclusions 
 
In this thesis microdermabrasion was evaluated as a skin permeability method for 
transdermal drug delivery. The parameters that resulted in controlled stratum corneum removal 
were evaluated. The types of drugs that could be delivered to abraded skin and the affect of 
abrasion depth were examined in vitro and in vivo. To determine the duration of drug and for 
safety, the rate of stratum corneum removal after abrasion was also studied. Microdermabrasion 
shows promise as a non-invasive delivery technique that can be used in conjunction with a patch 
to administer drugs.   
This study we sought to determine the parameters that would result in controlled 
microdermabrasion could selectively remove stratum corneum in a targeted fashion without 
removing viable epidermis. Crystal flow rate and exposure time were the most important 
parameters in controlling stratum corneum removal, whereas suction pressure and handpiece 
movement had lesser effects. Notably, this study introduced the use of a mask to limit tissue 
removal to an array of micron-scale pores rather than one large region of stratum corneum 
removal. We found that the mask also influenced the depth of tissue removal; the 125 µm-hole 
mask limited tissue removal to the stratum corneum in a self-limiting manner independent of 
exposure time to microdermabrasion. In this way, precise control over pore geometry was 
achieved such that arrays of pores on the order of 100 µm in diameter and 10 µm in depth (i.e., 
the thickness of stratum corneum) were demonstrated. Because stratum corneum is the skin’s 
main permeability barrier, controlled microdermabrasion offers a novel approach to increasing 
rates of transdermal drug delivery. The established clinical safety record and the non-invasive 
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nature of microdermabrasion suggest that this approach should be safe, painless, cosmetically 
acceptable and effective to deliver a broad range of pharmaceutical compounds.  
 After finding parameters that selectively remove stratum corneum, microdermabrasion 
was used to deliver sulforhodamine, insulin, BSA, and influenza vaccine in vitro. Along with 
removing stratum corneum, we also removed viable epidermis to determine the affect of the 
depth of abrasion. Full thickness porcine that was abraded without a mask and split thickness 
human cadaver skin that was abraded through a mask were exposed to different molecules. 
Removing the stratum resulted in an increase in the penetration of all the molecules, while 
removing the viable epidermis resulted in a larger molecule penetration. The molecule diffusion 
was dependant on the drug’s molecular weight and the depth of abrasion. Sulforhodamine 
diffused through the skin readily, while Texas red bovine serum albumin and influenza did not 
penetrate the full thickness of the skin. At 12 h for split thickness skin with the viable epidermis, 
sulforhodamine B penetration was 600 times higher than the insulin penetration. 
Microdermabrasion shows promise as a transdermal technique that can be used to deliver 
therapeutics to the skin. 
We showed that microdermabrasion can be used to deliver insulin in diabetic rats. The 
rate of insulin delivery was dependant on by the abrasion depth. Removing stratum corneum 
resulted in a decrease in the blood glucose, but there was a two hour lag time and largest 
decrease in the cumulative blood glucose was 46 points. While, removing the viable epidermis 
resulted in a 30 min time lag and the largest cumulative blood glucose drop was 146 points. The 
blood glucose behavior for the two groups were significantly different from each other, which 
demonstrated that removing the viable epidermis was important in delivering insulin. Increasing 
the abrasion depth increased the penetration of insulin and significantly decreased the lag time 
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and animal mortality. The viable epidermis is important barrier that is often overlooked for 
transdermal therapies and by removing it, the amount of drugs that can be delivered into the skin 
increases greatly. 
The skin resealing study examined the rate of barrier recovery and the affect of occlusive 
and non-occlusive wound coverings on the kinetics of stratum corneum recovery in guinea pigs 
after microdermabrasion. The barrier, for wound coverings, was determined to be reformed and 
functional within 12 hours using electrical resistance and histology. Based on statistics, there was 
no difference between occlusion and non-occlusion on the rate of healing of the stratum corneum 
removal in hairless guinea pigs. This is possibly due to wound being superficial (15 µm deep), 
the size of the wound, and the large number of hair follicles. The healing of the skin is important 
for safety and will determine the range of drugs that can be delivered using microdermabrasion. 
 Overall, the finding of this thesis show that: (i) controlled microdermabrasion can remove 
the stratum corneum, the main barrier to drug delivery and (ii) hydrophilic macromolecules can 
penetrate abraded skin in significantly higher amounts than intact skin and (iii) drug delivered 
after microdermabrasion in vivo can elicit a therapeutic response and (iv) the depth of abrasion 
significantly impacts the rate of drug diffusion into the skin and (v) the skin reseals rapidly in 
guinea pigs after microdermabrasion treatment.  Microdermabrasion has the potential to advance 
the field of transdermal drug delivery and increase the number of therapeutics that can delivered 







Chapter 9: Recommendations 
 
 This thesis work found that controlled microdermabrasion could be used to remove the 
stratum corneum to increase the skin’s permeability to water soluble molecules, proteins, and 
vaccines. We also found that the depth of abrasion significantly impacted the rate of drug 
delivery. Removing the viable epidermis reduced the diffusion lag time and up to 13 times more 
drug was delivered as compared to removing the stratum corneum. Future studies should explore 
controlled viable epidermis removal with a mask to determine the range of molecules that can be 
delivered, such as vaccines, and elicit a therapeutic response. The rate of skin healing after 
removing the viable epidermis should also be studied to make sure there are no adverse effects of 
removing the layer. The healing study will also determine how long the molecule can be 
delivered and if occluding the area will decrease the rate of healing. 
 Since all the studies were conducted on guinea pigs, in vivo studies using humans should 
be conducted to determine if a therapeutic dose of insulin can be delivered after abrasion. The 
study can be conducted in conjunction with a skin resealing study to determine the length of time 
insulin can penetrate the skin. The mask can also be redesigned to allow a larger area of abrasion 
for insulin delivery. 
 The safety of repeated abrasions should be investigated. Clinically, the skin is abraded 
repeatedly over several weeks. However, the stratum corneum or full epidermis is typically not 
completely removed. Studies should examine the affect of serial abrasion to measure the change 
in the thickness and mechanical properties of the stratum corneum and viable epidermis and if 
the settings must be adjusted to remove the layers. 
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 Pain in human subjects should also be investigated for stratum corneum and full 
epidermis removal. Clinically, microdermabrasion has been shown to not cause pain however, 
the stratum corneum and full epidermis are not typically removed. A pain study in which the 
stratum corneum and full epidermis is removed, using the mask, should be conducted. Patients 
can rank the pain using a pain intensity scale. Subjects can also compare the pain felt during 
microdermabrasion to that of a hypodermic needle to determine which method they would prefer 
for drug delivery. 
 To make the device of use for self administration, a handheld abrasion device that has 
sensors to control the depth of skin abrasion should be developed. The device should be compact 
and will rely on the sensors to determine when the stratum corneum or full epidermis has been 
removed. The sensors can measure the skin’s electrical resistance and should turn off and lock 
the device when the abrasion depth is reach to prevent overabrasion. The device can be coupled 
with a transdermal patch to deliver the therapeutic. The device can be designed to also work in 












Appendix A: Microdermabrasion Device 
 
 The schematic of MDA device was described and shown in the Introduction section. A 
picture of the actual device is shown in Figure 32. Figure 32A shows the front of the device and 
all the components are labeled. The crystal flow rate and pressure are controlled by the crystal 
and vacuum knobs, respectively. The crystal flow rate depends on the number of turns of the 
crystal knob. The flow rate decreases with increasing turns of the knob, which indicates closing 
of the valve. The pressure ranges from -20 to -60 kPa and the value is displayed on the pressure 
gauge. The crystals flow from the machine to the handpiece, shown in Figure 32B, through the 
outlet port and impact the skin. The skin debris and used crystals are suctioned to the waste 
container in the machine through the inlet port. The gold handpiece assembly shown in Figure 
32B is the most aggressive tip that can be used for abrasion and it was used for this thesis. The 
tip has an open orifice that allows maximum crystal flow. The crystals, waste container, and the 
plastic handpiece tips were purchased from the manufacturer (DermaMed USA, Lenni, PA). The 
device was not altered in any manner. 
 
Figure 32. Picture of the MDA device. 
103 
 
Appendix B: Microdermabrasion Device Characterization 
 
Introduction 
 In this study, we used the DermaMed Goldseries microdermabrasion device. Because the 
manufacturer provides little information to characterize the device’s operating parameters, and 
not much additional information exists in the literature, we carried out a detailed characterization 
in order to better understand device performance and interpret our data.  
The device has two settings that can be controlled by the operator: “vacuum,” which is 
the suction pressure measured in gauge units of kPa, and “crystal,” which is the crystal flow rate 
measured in relative units ranging from 0 (highest flow rate) to 9 (lowest flow rate) knob turns. 
We first sought to quantify crystal flow rate in absolute units (i.e., particles per second and mass 
per second) by directly measuring the mass moving through the machine. We next determined 
particle velocity as a function of operating conditions using video microscopy. 
 
Materials and methods 
The crystal mass flow rate was determined as a function of suction pressure at -30, -40, -
50, and -60 kPa and crystal flow rates corresponding to 0, 1, 3, 4, 6, and 9 knob turns for 3 to 60 
s. Zero knob turns is the maximum valve opening, whereas at nine turns the valve is almost 
closed. The absolute crystal flow rate at each turn has not been previously characterized by the 
manufacturer. Our experiments were carried out by weighing the microdermabrasion device 
waste container prior to the experiment with a BP 2100 Sartorius balance (Sartorius Group, 
Goettingen, Germany). The device was then set to a specified pressure and crystal flow rate, and 
porcine skin was abraded using the static mode. The final weight of the waste container was 
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measured at the conclusion of the experiment, and the mass of the crystals consumed was 
determined by subtracting the final canister mass from the initial mass. Measurements at each 
setting were carried out in triplicate. 
 To convert mass flow rate into particle flow rate, we used the following equation: P = M / 
m, where P is particle flow rate (particles/s), M is mass flow rate (g/s), and m is the average 
particle mass, which was determined to be 3 µg per particle. The average particles mass was 
estimated by counting the number of particles in a 2.2 mg sample of particles by microscopic 
imaging and averaging the result of three replicate measurements. 
The velocity of the particles was measured using a Phantom B4.2 high speed camera 
(Vision Research, Wayne, NJ). The camera imaged the particles in the handpiece tip at pressures 
of -30, -40, and -50 kPa and at crystal flow rates corresponding to 0, 3, 6, and 9 turns. Particle 
velocity was also measured for -60 kPa for 1 and 4 turns. The videos were captured using the 
Phantom Camera Control software (Vision Research) and analyzed using Image J (National 
Institutes of Health, Bethesda, MD), QuickTime (Apple, Cupertino, CA), Microsoft Office 
Picture Manager (Microsoft, Redmond, WA), and Digitizing Tools Software (Hendricks Lab, 
Chapel Hill, NC) [31]. Each video was recorded for 0.54 s at a capture rate of 10,000 frames/s. 
Four videos of each setting were recorded and, for each video, 20 particles were tracked over 10 
frames to determine the velocity by directly measuring the distance traveled per time increment.  
 
Results 
Crystal Mass and Particle Flow Rate 
The crystal mass and particle flow rates were determined as a function of crystal flow 
rate knob turns and as a function of pressure. Figure 33A shows the mass flow rate over time at 
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crystal knob settings of 1, 3, 6, and 9 turns at a suction pressure of -50 kPa. These data show that 
(i) mass flow rate did not significantly change with time at all crystal flow rate knob turns (two-
way ANOVA, P ≥ 0.05) and (ii) mass flow rate increased with decreasing crystal flow rate knob 
turns (two-way ANOVA, P < 0.05). In Figure 33B, mass flow rate is shown over time as a 
function of suction pressure. Over the range of conditions studied, suction pressure did not 
significantly affect the crystal mass flow rate (two-way ANOVA, P > 0.05). Mass flow rate data 




Figure 33. Crystal mass flow rate and particle flow rate shown as a function of time at different crystal knob turns 
and suction pressures. (A) Mass and particle flow rates at 1, 3, 6, and 9 knob turns at a suction pressure of -50 kPa in 
the static mode. (B) Mass and particle flow rate at suction pressures of -30, -40, and - 50 kPa at a crystal flow rate at 
3 turns in the static mode. Data represent the average of three replicate measurements ± standard deviation.  
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Guided by the observation that crystal flow rate is generally independent of time, we 
determined mass flow rates over a broader range of suction pressures and crystal flow rates, 
which is shown in Figure 34. These data further demonstrate that crystal mass flow rate depends 
on the crystal knob setting (two-way ANOVA, P < 0.05) and does not depend on suction 
pressure (two-way ANOVA, P > 0.05). Over the range of conditions used in this study (which 
generally spans the range of conditions enabled by the microdermabrasion machine), crystal 
mass flow rates varied up to more than 0.7 g/s and 2 x 10
6
 particles/s.  
 
Figure 34. Mass flow rate is shown as a function of suction pressure and number of turns of the crystal flow rate 
knob applied in the static mode. Data represent the average of three replicate measurements. Error bars are not 
shown to simplify the presentation. The magnitude of the error bars in these data is similar to those shown in Figure 
33A.   
108 
 
Crystal Velocity  
 Average crystal particle velocity was measured as a function of crystal flow rate and 
suction pressure, as shown in (Figure 35). These data show that velocity varied with crystal flow 
rate (two-way ANOVA, P < 0.05) but did not depend on suction pressure (two-way ANOVA, P 
> 0.05). More specifically, particle velocity was generally slower at higher particle flow rates 
(i.e., smaller number of crystal flow rate knob turns). Particle velocities ranged from 
approximately 1 m/s to 3.5 m/s under the conditions used in this study (which generally span the 
range of conditions enabled by the microdermabrasion machine).  
 
Figure 35. Average crystal particle velocity shown as a function of the number of turns of the crystal flow rate knob 
at different suction pressures. Data represent the average of 20 particle measurements ± standard deviation.  
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Closer examination of the video images used to determine particle velocity shows that the 
slower particle speed at higher particle flow rates appears to be due to the higher density of 
particles in the handpiece, which results in larger numbers of particle-particle collisions, thus 
reducing the particles’ speed. The videos also show evidence of particles breaking apart upon 
collision, which increases particle number and decreases particle size.  
 
Discussion and conclusion 
This study provides the first detailed characterization of the physical operating 
parameters of this or, to our knowledge, any microdermabrasion machine. The mass flow rate, 
particle flow rate, and particle velocity were determined over most of the range of operating 
conditions enabled by the machine. The mass flow rate and particle flow rate increased as the 
opening of the crystal flow rate valve increased (i.e., at decreasing crystal flow rate knob turns). 
Mass flow rates ranged up to more than 0.7 g/s and particle flow rates ranged up to more than 2 x 
10
6
 particles/s. Crystal flow rate was found to be independent of time and suction pressure. 
Particle velocity was shown to vary between 1.0 cm/s and 3.5 cm/s and to decrease at increasing 











Appendix C: In vitro Drug Delivery Apparatus Schematic 
 
 As stated in the Material and Methods section, the in vitro drug delivery experiments 
were carried using horizontal and vertical diffusion chambers (PermeGear, Hellertown, PA). The 
SR experiments were carried out using horizontal diffusion chambers that used a water circulator 
to flow water through the outer jacket of the chambers to maintain a constant temperature (37 
°C). The constant temperature eliminated the effects of a thermal gradient on diffusion. The 
chambers were placed on stir plates to allow adequate mixing. A schematic of the horizontal 
chamber set up is shown in Figure 36. The skin is positioned between the donor and receiving 
chamber and the skin surface was exposed to the donor solution. The donor and receiving 
chambers were each filled with 3 mL of the drug solution and PBS, respectively. The receiving 
chamber solution was sampled every hour for 24 h and the fluorescence was measured using a 
spectrofluorometer. Fresh PBS was added to the receiving chamber at each sample time point. 
The horizontal chambers have a 3.4 mL capacity for both chambers, which allows large volumes 
of drugs to be used for the diffusion experiments. However they are not ideal for expensive 




Figure 36. Schematic of the horizontal diffusion chamber drug delivery equipment. Pictures adapted from 
www.permegear.com. 
The BSA, influenza vaccine, and mask experiments were carried out using vertical Franz 
cell diffusion chambers. The vertical chambers allowed smaller donor chamber volumes. The 
vertical and horizontal chambers function in the same manner, except the vertical chambers are 
placed individually in a heating block to maintain the temperature (37 °C). A schematic of the 
vertical chamber equipment setup is shown in Figure 37. The skin was loaded in the chambers 
using the same protocol as the horizontal chambers. One hundred microliters of the drugs were 
loaded in the donor chamber and 5 mL of PBS was added to the receiving chambers. The donor 
chamber was covered with parafilm to prevent the donor solution from evaporating. The 
receiving chamber for the BSA and influenza studies was not sampled since it was determined 
during preliminary experiments that BSA does not penetrate the entire thickness of the dermis 
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over the timescales using in this study. The receiving chamber for the sulforhodamine mask 
experiment was sampled every hour for 12 h. The receiving chamber for the insulin delivery 
mask study was sampled every 6 h for 54 h. For both experiments all of the PBS from the 
receiving chamber was removed and the amount of drug in the solution was quantified with a 
spectrofluorometer. Fresh PBS was added to the chamber at each sampling point. 
 










Appendix D: Influenza A Drug Delivery Study 
 
The goal of this experiment was to evaluate MDA as an immunization method for 
delivering influenza A vaccine to guinea pigs after a single vaccination.  
 
Material and methods 
 Eight hairless guinea pigs (IAF strain, Charles River Laboratories, Wilmington, MA) 
were divided equally into two groups. Blood was collected from the animals one day prior to the 
experiment for baseline antibody measurements. One group received an intramuscular (IM) 
injection of 10 µg of PR8 inactivated influenza A virus. The second group was anesthetized with 
ketamine-xylaxine and abraded using the setting -40 kPa for 10 passes (1 pass/sec) at half of the 
crystal flow rate.  After abrasion, a transdermal patch was placed on the animal and filled with 
200 µL of 15 µg of PR8 inactivated influenza virus solution. The patch was removed after 24 h 
and the skin was wiped cleaned. Blood was collected 15 and 30 days after immunization for 
ELISA and the Hemagglutinin Inhibition (HAI) assay. 
 
ELISA Protocol 
 ELISA was used to detect antibodies in the animal serum that were produced in response 
to the vaccination. The assay was conducted by first coating each of the wells of the 96-well 
plate with 100 µL of inactivated purified PR8 virus (5 ng/mL). The wells for the standard curve 
were coated with 100 µL of 2 µg/µL antibody solution. The plate was incubated over night at 4 
°C.  After incubation, the plate was washed three times with PBS. The wells were filled with 200 
µL of blocking buffer, comprised of PBS and 3 % BSA, and the plate was incubated for 1 h at 37 
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°C.  At the end of the incubation period, the plate was washed three times with PBS.  One 
microliter of guinea pig serum and 100 µL of the primary antibody in a 1:100 dilution ratio were 
added to the wells. The primary antibody was diluted in PBS. Primary antibody standards were 
also added in concentrations ranging from 1 to 1000 ng/mL. The plate was incubated for 1.5 
hours at 37 
o
C.  After the incubation the plate was washed three times with PBS. One hundred 
microliters of the secondary antibody was added in a dilution ratio of 1:1000. The plate was 
incubated for 90 min at 37 °C. The plate was washed three times using PBS and 100 µL of an 
enzyme solution was added to each well for one minute. After 1 min, 50 µL of H3P04 stop 
solution was added to the wells to stop the enzymatic reaction. The absorbance of the wells was 
measured at 450 nm using a plate reader.  
 
Hemagglutinin Inhibition Protocol 
The HAI assay was carried out to test the quality of the antibodies in the sera that were 
produced in response to the influenza immunization. Prior to the assay, the serum was separated 
from the blood by centrifugation. To begin the assay, 10 µL of serum was mixed with 30 µL of 
receptor destroying enzyme and incubated in a 56 °C water bath for 1 h to deactivate the 
complement. After the incubation, the serum mixture was cooled to reach room temperature and 
60 µL PBS was added to the solution to bring the concentration of the serum to a 1:10 dilution 
ratio. Twenty-five microliters of PBS was added to each of the wells and then sera was added to 
all wells in serial dilutions from column 1 to column 12 by adding 25 µL to each well from the 
previous well. The plate was mixed and incubated at room temperature for 15 to 30 min. After 
incubation, 50 μL of 0.5% Red Blood Cells (RBCs) was added to each well. A positive control 
(25μL PBS + 50 μL of RBCs) and negative control (25μL virus + 50 μL of RBCs) was also 
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added to the plate. The plate was incubated for 1 h or until positive control formed a pellet. The 
value for HAI is when pellet becomes less than a complete pellet. Seroprotective results must 
have a 1:40 or greater ratio. 
 
Results 
 The ELISA and HAI results indicated that the guinea pigs immunized using 
microdermabrasion did not have seroprotection against the PR8 vaccine. However, we did not 
challenge the guinea pigs with a lethal dose of influenza A to confirm the results. The HAI assay 
determined that the negative control (naïve) and microdermabrasion treated groups had a value 
of 10. The intramuscular group on day 15 and 30 had a HAI value of 80 and 160, respectively. 
HAI seroprotection in humans is determined to be significant if the value is over 40. Using a 
one-way ANOVA it was determined that microdermabrasion treated group was not significantly 




 Based on the results, it was shown that using MDA to immunize guinea pigs was not 
effective in eliciting a protective immune response after a single vaccination. Several studies 
have used transcutaneous methods to deliver vaccines, however, most vaccinations require 
multiple boosts, penetration enhancers, or adjuvants to illicit a protective immune response [63, 
78]. Penetration enhancers alter the SC structure to increase the skin’s permeability to 
hydrophilic molecules [21].  Adjuvants are compounds, such as cholera toxin, that stimulate an 
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 Microdermabrasion was not effective in immunizing guinea pigs using a single 
vaccination in this study. Multiple boosts may be needed to provide a strong immune response 
against influenza. Removing the epidermis may also increase the potency of the vaccine as 
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